<< مقالات لاتين >>
<< بر اساس عنوان >>
1
Anesthesia for Trans Sternal Thymectomy: Modified Non-muscle Relaxant Technique
2
Anesthesia in a pediatric patient with Xeroderma pigmentousoma: A case report
3
Anesthesia in an adult patient with patent ductus arteriosus
4
Anesthesia in multiple sclerosis and obstructive sleep apnea: case report and literature review
5
Anesthesia in peripartum cardiomyopathy
6
Anesthesia Inhibits Interferon-Induced Natural Killer Cell Cytotoxicity via Induction of CD8+ Suppressor Cells
7
Anesthesia Issues and Challenges: An African Perspective
8
Anesthesia Length in Ultra Rapid Opioid Detoxification
9
Anesthesia Management for the Patient with Chronic Decompensated Heart Failure and Low Cardiac Output Undergoing CABG with Advanced Cardiac Monitoring: A Case Report
10
Anesthesia Management in a Case of Apert Syndrome
11
Anesthesia Management in a Child with Letterer Siwe Disease
12
Anesthesia Management in a Hypertrophic Cardiomyopathy Patient with Brain Tumor: A Case Report
13
Anesthesia Management in a Patient with Kabuki Syndrome
14
Anesthesia Management in a Patient with Patau Syndrome Who Underwent Bilateral Vitrectomy
15
Anesthesia Management in Achondroplasia: A Case Report
16
Anesthesia Management in an 11-Month Old Infant with Pompe Disease
17
Anesthesia Management in an Edentulous Patient with Huge Parotid Tumour: Case Report
18
Anesthesia Management in Patient with Plasminogen Deficiency for Cesarean Section (C/S): A Case Report
19
Anesthesia Management in Rare Case: Cutis Laxa Syndrome
20
Anesthesia Management in Redo Mitral Valve Replacement Surgery in a Patient with a Rare Blood Group: A Case Report
21
ANESTHESIA MANAGEMENT OF A JEHOVAH’S WITNESS PATIENT WITH PHEOCHROMOCYTOMA UNDERGOING OFF PUMP CORONARY ARTERY BYPASS GRAFT SURGERY - A Case Report -
22
Anesthesia Management of a Patient with Lumbar Spinal Stenosis and Tracheal Stenting
23
Anesthesia Management of a Patient with Papillon-Lefevre Syndrome: A Case Report
24
Anesthesia Management of Electroconvulsive Therapy at the Late of Pregnancy: A Case Report
25
Anesthesia Management of Vitrectomy in a Patient with Sturge-Weber Syndrome
26
Anesthesia Methods in Pregnant Women: A Review Study
27
Anesthesia of juvenile Persian sturgeon, Acipenser persicus; Borodin 1897, by peppermint, Mentha piperita, extract – Anesthetic efficacy, stress response and behavior
28
ANESTHESIA OUTCOME PREDICTION
29
Anesthesia Preoperative Clinic Evaluation of Obstructive Sleep Apnea Using Nasal Fiberoptic Videoendoscopy: A Pilot Study Comparison with Polysomnography
30
Anesthesia Preoperative Clinic Referral for Elevated Hba1c Reduces Complication Rate in Diabetic Patients Undergoing Total Joint Arthroplasty
31
ANESTHESIA PROTOCOL FOR LIVER TRANSPLANT
32
Anesthesia Related Complications of Gastrointestinal Endoscopies; A Retrospective Descriptive Study
33
Anesthesia Teaching for Undergraduates; Bringing the Operating Theatre to the Simulation Lab: A Pilot Study
34
Anesthesia technique and serum cytokine concentrations in the elective cesarean section
35
Anesthesia Techniques in In-Office Aesthetic Surgery: A Narrative Review
36
Anesthesia Type and Short-Term Outcomes in Open Treatment of Hand Fractures
37
ANESTHESIA WITH ETOMIDATE AND REMIFENTANIL FOR CESAREAN SECTION IN A PATIENT WITH SEVERE PERIPARTUM CARDIOMYOPATHY- A Case Report -
38
Anesthesia with Propofol in Grass Carp, Ctenopharyngodon idella, and its Effects on Electrocardiogram, Blood Gases and pH
39
Anesthesia, complications, and clinical outcome for ruptured intracranial aneurysms: a retrospective comparison between endovascular coiling and neurosurgical clipping
40
Anesthesia, Neural Information Processing, and Conscious Awareness
41
Anesthesia: Part of the solution
42
Anesthesia: The “Other Side” of Consciousness
43
Anesthesia—A Descent or a Jump into the Depths?
44
Anesthesia-Related Complaint Cases at Kermanshah Medical Council Between 1993 and 2011
45
Anesthesia-related morbidity and mortality: where are we? A descriptive study
46
Anesthésie générale en radiothérapie pédiatrique
47
Anesthesiologic and Surgical Experiences of the Spanish Role 2 Enhanced in Herat, Afghanistan
48
Anesthesiological approach to a case with FAHR syndrome
49
Anesthesiologist’s Perspective on a Child with Acute Lymphoblastic Leukemia undergoing Neurosurgery: Case Report
50
Anesthesiologists Have an Important Role in Preclinical Nurse Anesthesia Education
51
Anesthesiology residents’ perception towards educational environment using ATEEM in a medical school in Thailand
52
Anesthesiomics: Could a New Name Be Coined for Anesthesia?
53
Anesthetic action: The importance of the spinal cord to immobility
54
Anesthetic and analgesic efficacy, hemodynamic changes, andsedation following addition of dexmedetomidine to lignocainein intravenous regional anesthesia for minor hand surgery
55
ANESTHETIC AND ICU MANAGEMENT OF PERIPARTUM CARDIOMYOPATHY
56
Anesthetic approach to Niemann–Pick Type C patient for dental treatment
57
Anesthetic approach to patient with Down syndrome and Hallervorden-Spatz disease who underwent tooth extraction
58
Anesthetic Approach to the Patient with Intraabdominal Pseudocyst After Ventriculoperitoneal Shunt Dysfunction Performed for Hydrocephalus
59
Anesthetic Aspect Of Malaria Disease: A Brief Review
60
ANESTHETIC CARE OF THE PATIENT FOR ROBOTIC SURGERY
61
ANESTHETIC CARE OF THE PATIENT WITH OBSTRUCTIVE SLEEP APNEA
62
ANESTHETIC CHALLENGES IN ORO-FACIAL CLEFT REPAIR IN ILE-IFE, Nigeria
63
Anesthetic Challenges in Pregnancy with Wilson’s Disease Associated with Massive Splenomegaly Complicated with Intramyometrial Carboprost: A Case Report
64
ANESTHETIC CONSIDERATION FOR GERIATRIC OUTPATIENT
65
Anesthetic Consideration of Niemann-Pick Disease Type C
66
Anesthetic Considerations and Management of a Patient with Unsuspected Carcinoid Crisis During Hepa tic Tumor Resection
67
Anesthetic Considerations for Angelman Syndrome: Case Series and Review of the Literature
68
Anesthetic Considerations for Cataract Surgery in Patients with Parkinson’s Disease: A Narrative Review
69
ANESTHETIC CONSIDERATIONS FOR PEDIATRIC CHEST TRAUMA
70
ANESTHETIC CONSIDERATIONS FOR THE NEONATE WITH TRACHEOESOPHAGEAL FISTULA
71
Anesthetic Considerations for the Patient with Systemic Lupus Erythematosus
72
Anesthetic Considerations in a Case of Peumatocele Following Chest Trauma: A Case Report
73
Anesthetic Considerations in a Case With Massive Recurrent Clivus Chordoma
74
Anesthetic considerations in a patient with Psoriasis undergoing CABG surgery
75
Anesthetic considerations in a patient with Takayasu’s arteritisfor cesarean section
76
Anesthetic considerations in medium-chain acyl-CoA dehydrogenase deficiency
77
Anesthetic Considerations in Patients Undergoing Bariatric Surgery: A Review Article
78
ANESTHETIC CONSIDERATIONS IN PATIENTS WITH CARDIOMYOPATHIES- A Review -
79
Anesthetic considerations of Palmoplantar Keratoderma (PPK), a case report.
80
Anesthetic Considerations of Patient with Parry Romberg Syndrome
81
Anesthetic Considerations of Sporadic Inclusion Body Myositis in an Elderly Man With Orthopedic Trauma
82
Anesthetic Control of 40-Hz Brain Activity and Implicit Memory
83
Anesthetic Conversion of Preexisting Labor Epidural Analgesia for Emergency Cesarean Section and Efficacy of Levobupivacaine with or Without Magnesium Sulphate: A Prospective Randomized Study
84
ANESTHETIC DEATHS IN A DEVELOPING COUNTRY
85
Anesthetic dental needle breakage
86
Anesthetic effect of tricaine methanesulfonate, clove oil and electroanesthesia on lysozyme activity of Oncorhynchus mykiss
87
Anesthetic effects of adding intrathecal neostigmine or magnesium sulphate to bupivacaine in patients under lower extremities surgeries
88
Anesthetic Efficacy of Articaine and Ketamine for Inferior Alveolar Nerve Block in Symptomatic Irreversible Pulpitis: A Prospective Randomized Double-Blind Study
89
Anesthetic efficacy of articaine/epinephrine plus mannitol in comparison with articaine/epinephrine anesthesia for inferior alveolar nerve block in patients with symptomatic irreversible pulpitis: A randomized controlled clinical trial
90
Anesthetic Efficacy of Inferior Alveolar Nerve Block: Conventional versus Akinosi Technique
91
Anesthetic efficacy of ketamine, ketaminetramadol and ketamineketorolac in chicks
92
Anesthetic Efficacy of Lidocaine/Ketorolac in Inferior Alveolar Nerve Block in Patients with Irreversible Pulpitis: A Randomized Clinical Trial
93
Anesthetic Experience of 1000 Cases During 10 Years in Renal Transplantation: A Retrospective Study
94
Anesthetic gas control with neuro-fuzzy system in anesthesia
95
ANESTHETIC IMPLICATIONS OF ACUTE METHYLENEDIOXYMETHAMPHETAMINE INTOXICATION IN A PATIENT WITH TRAUMATIC INTRACEREBRAL HEMORRHAGE - Case Report-
96
Anesthetic Management “Arnold Chiari Malformation” in the well-known Case of Cystic Fibrosis
97
Anesthetic management and perioperative complications in transcatheter aortic valve implantation: the Turkish experience
98
Anesthetic Management and Postoperative Care of a Patient with CADASIL (Cerebral Arteriopathy, Autosomal Dominant, with Subcortical Infarcts and leukoencephalopathy) for Cesarean Section
99
Anesthetic management for elective lower segment cesareansection in a patient with systemic lupus erythematosus andthrombocytopenia
100
Anesthetic Management for Lower Limb Fracture in Severe Aortic Valve Stenosis and Fat Embolism: A Case Report and Review of Literature
101
Anesthetic Management for Tracheo-Bronchial Reconstruction
102
Anesthetic Management in a Child With Citrullinemia: A Case Report
103
Anesthetic Management in a Child With Niemann-Pick Disease
104
ANESTHETIC MANAGEMENT IN A PATIENT WITH CORNELIA DE LANGE SYNDROME
105
Anesthetic Management in a Patient with Mixed Connective Tissue Disease: a Case Report
106
Anesthetic Management in a Patient With Surgical Excision of Spinal Cords Hydatid Cyst: A Case Report
107
Anesthetic Management in a Patient With Type A Aortic Dissection and Superior Vena Cava Syndrome
108
Anesthetic Management in Complex Arch Surgery: Debranching of Innominate and Left Common Carotid Arteries in Extensive Aortic Dissection without Cardiopulmonary Bypass
109
Anesthetic Management of 29 Week Pregnant Patient Undergoing Craniotomy for Pituitary Macroadenoma
110
Anesthetic Management of a Case of Duchenne Muscular Dystrophy in Congestive Heart Failure with Compartment Syndrome of the Upper Limb for Emergency Fasciotomy
111
Anesthetic management of a dog with severe subaortic stenosis and mitral valve disease complicated with atrial fibrillation undergoing ovariohysterectomy
112
Anesthetic management of a low birth weight infant with immature teratoma
113
ANESTHETIC MANAGEMENT OF A MORBIDLY OBESE PARTURIENT UNDERGOING CESAREAN SECTION
114
ANESTHETIC MANAGEMENT OF A NEWBORN WITH A CERVICAL MENINGOMYELOCELE
115
Anesthetic Management of a Parturient with Spinal Muscle Atrophy for Cesarean Section: A Case Report
116
Anesthetic Management of a Patient with Achondroplasia Undergoing Adenotonsillectomy: A Case Report
117
Anesthetic Management of a Patient with DRESS Syndrome for Renal Transplantation
118
ANESTHETIC MANAGEMENT OF A PATIENT WITH HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY UNDERGOING MODIFIED RADICAL MASTECTOMY
119
Anesthetic Management of a Patient with Myasthenia Gravis
120
ANESTHETIC MANAGEMENT OF A PATIENT WITH MYOTONIC DYSTROPHY FOR LAPAROSCOPIC CHOLECYSTECTOMY - A Case Report -
121
Anesthetic management of a patient with Nager Syndrome
122
Anesthetic management of a patient with β -thalassemia and superimposed pneumonia
123
Anesthetic Management of a Pediatric Patient with Arginase Deficiency
124
Anesthetic management of a scleroderma patient undergoing tricuspid valve replacement under cardiopulmonary bypass
125
ANESTHETIC MANAGEMENT OF ACHONDROPLASTIC DWARF UNDERGOING CESAREAN SECTION
126
Anesthetic Management of Achondroplastic Dwarf with Difficult Airway for Cadaveric Renal Transplantation: A Case Report
127
Anesthetic Management of an Infant Presenting with an Intrapericardial Tumor: A Case Report
128
Anesthetic Management of an Infant with Bilateral Radial Dysplasia and Isolated Patent Ductus Arteriosus: A Case Report and Brief Review of Literature
129
Anesthetic management of carcinoma of thyroid involving trachea in a patient with hypertrophic obstructive cardiomyopathy
130
Anesthetic Management of Cervical Disc Herniation in a Patient with Churg-Strauss Syndrome: A Case Report
131
Anesthetic Management of Cervical Disc Herniation in a Patient with Churg-Strauss Syndrome: A Case Report
132
Anesthetic management of children with Moyamoya disease
133
ANESTHETIC MANAGEMENT OF CHILDREN WITH RUBINSTEIN-TAYBI SYNDROME
134
Anesthetic management of conjoined twins undergoing one-stage surgical separation: A single center experience
135
Anesthetic Management of COVID-19 Associated Mucormycosis: A Narrative Review
136
ANESTHETIC MANAGEMENT OF CRITICALLY ILL PREGNANT WOMEN
137
Anesthetic management of diaphragmatic hernia repair in a dog: a case report and literature review of anesthetic techniques
138
Anesthetic Management of Difficult Airway Due to Maxillofacial Trauma in a Pregnant Patient Requiring Submental Intubation: A Case Report
139
ANESTHETIC MANAGEMENT OF DILATED CARDIOMYOPATHY - A Case report -
140
Anesthetic Management of Hysterosalpingo-oophorectomy in a Case with Severe Idiopathic Dilated Cardiomyopathy
141
ANESTHETIC MANAGEMENT OF IATROGENIC ESOPHAGEAL PERFORATION - Case Report and Literature Review -
142
Anesthetic management of ischemic heart disease with ejectionfraction of 35% in a patient of fracture neck femur
143
Anesthetic Management of Jervell and Lange-Nielsen Syndrome With Long QT Undergoing Surgical Sympathectomy: A Pediatric Case Report
144
Anesthetic management of laparoscopic dual renal transplantation
145
Anesthetic Management of Patients With Anterior Mediastinal Masses Undergoing Chamberlain Procedure (Anterior Mediastinostomy)
146
Anesthetic management of patients with Klippel-Feil syndrome, a case series
147
ANESTHETIC MANAGEMENT OF PEDIATRIC CARDIAC PATIENTS UNDERGOING NON CARDIAC SURGERY
148
ANESTHETIC MANAGEMENT OF PHEOCHROMOCYTOMA
149
Anesthetic Management of Rapid Ventricular Response Atrial Fibrillation in an Elderly Woman Using Remifentanil; A Case Report
150
Anesthetic Management of Simultaneous Coronary Artery bypass Grafting with Cardiopulmonary bypass and Extended Thymectomy in a Patient with Myasthenia Gravis
151
Anesthetic Management of T12 Schwannoma in a Patient with Churg-Strauss Syndrome: A Case Report
152
Anesthetic Management of Total Traumatic Avulsion of Mandible
153
Anesthetic Management ofUrgent Cesarean Section withUndiagnosed Transposition ofGreat Arteries
154
Anesthetic Management Recommendations Using a Machine Learning Algorithm to Reduce the Risk of Acute Kidney Injury After Cardiac Surgeries
155
Anesthetic Management with Epidural Analgesia in a Case of Thalassemia Intermedia
156
Anesthetic methods for reduction of acute shoulder dislocations: A prospective randomized study comparing intraarticular lidocaine with intravenous analgesia and sedation
157
Anesthetic pentobarbital inhibits proliferation and migration of malignant glioma cells
158
Anesthetic Propofol-Induced Gene Expression Changes in Patients Undergoing Coronary Artery Bypass Graft Surgery Based on Dynamical Differential Coexpression Network Analysis
159
Anesthetic Technique in a Patient With Multiple Sclerosis Scheduled for Laparoscopic Nephrectomy for a Renal Tumor: A Case Report
160
Anesthetic Technique Influences Brain Temperature During Cardiopulmonary Bypass in Dogs
161
Anesthetic techniques for pediatric thoracoscopy
162
ANESTHETIST EXPERIENCE FOR CLEFT LIP AND CLEFT PALATE REPAIR: A REVIEW OF 172 SMILE TRAIN SPONSORED PATIENTS AT HAYAT ABAD MEDICAL COMPLEX, PESHAWAR
163
AnestimationmethodforbasematupliftbehaviorofnuclearpowerplantbuildingsOriginalResearchArticle
164
Anethole, a Medicinal Plant Compound, Decreases the Production of Pro-Inflammatory TNF-α and IL-1β in a Rat Model of LPS-Induced Periodontitis
165
Anethum graveolens and hyperlipidemia: A randomized clinical trial
166
Anethum graveolens L. Alleviates Sperm Damage by Limiting Oxidative Stress and Insulin Resistance in Diabetic Rats
167
Anethum Graveolens Linn (Umbelliferae) Extract Attenuates Stress-induced Urinary Biochemical Changes and Improves Cognition in Scopolamineinduced Amnesic Rats
168
Anethum graveolens seeds aqueous extract stimulates whole brain 5-hydroxytryptamine metabolism and reduces feeding behavior and body weight in obese rats
169
Anethum graveolens Supplementation Improves Insulin Sensitivity and Lipid Abnormality in Type 2 Diabetic Patients
170
Anethum graveolens, A new host of Meloidogyne incognita in Turkey
171
Aneugenic 2,4-dihydroxy-7-methoxy-1,4-benzoxazin-3-one (DIMBOA) and 2,4-dihydroxy-1,4-benzoxazin-3-one (DIBOA) in sprouts of Triticum aestivum cultivars – A ‘safety health food’?
172
AN-EUL method for automatic interpretation of potential field data in unexploded ordnances (UXO) detection
173
Aneuploidies, deletion, and overexpression of TP53 gene in intestinal metaplasia of patients without gastric cancer
174
Aneuploidy Acts Both Oncogenically and as a Tumor Suppressor
175
Aneuploidy and Consistent Structural Chromosome Changes Associated with Transformation of Syrian Hamster Embryo Cells
176
Aneuploidy as a counter to “Mullerʹs ratchet” in cancer cells
177
Aneuploidy frequencies in semen fractions from ten oligoasthenoteratozoospermic patients donating sperm for intracytoplasmic sperm injection
178
Aneuploidy of chromosome 20 in invasive breast cancer correlates with poor outcome
179
Aneuploidy Precedes and Segregates with Chemical Carcinogenesis
180
Aneuploidy theory explains tumor formation, the absence of immune surveillance, and the failure of chemotherapy
181
Aneuploidy Underlies Rapid Adaptive Evolution of Yeast Cells Deprived of a Conserved Cytokinesis Motor
182
Aneuploidy, chromosomal missegregation, and cell cycle reentry in Alzheimer’s disease
183
Aneurismal disease of different vascular territories: Is it a rare association?
184
Aneurysm after subclavian flap angioplasty repair of coarctation of the aorta
185
Aneurysm at the fenestrated anterior cerebral artery: Surgical anatomy and management
186
Aneurysm formation after patch aortoplasty repair (vossschulte): reoperation in adults with and without hypothermic circulatory arrest
187
Aneurysm of a Right-Sided Descending Aorta With a Normal Left-Sided Aortic Arch
188
Aneurysm of ascending and descending aorta in a 10-year-old-boy with Wiskott-Aldrich syndrome
189
Aneurysm of Brachial Artery Following Axillary Crutch
190
Aneurysm of circumflex coronary artery caused by cardiac vein and fistulous connection to the left ventricle identified on MDCT
191
Aneurysm of fossa ovalis in adults: A pathologic study
192
Aneurysm of saphenous vein bypass graft detected by first-pass radionuclide ventriculography, , ,
193
Aneurysm of saphenous vein graft causing anterior myocardial infarction by possibly compressing left internal mammary artery
194
Aneurysm of Sinus of Valsalva Dissecting Into Interventricular Septum
195
Aneurysm of sinus of Valsalva with extensive dissection of interventricular septum and left ventricular free wall
196
Aneurysm of the aortic root in the setting of Wiskott-Aldrich syndrome
197
Aneurysm of the iliac artery in an infant: Diagnosis by angiography with computed tomography (In French) : Arnould V, Worms A-M, Galloy M-A, Hoeffel J-C (J.C.H.: Service de Radiologie, Hôpital dʹEnfants de Vandoeuvre les Nancy, allée du Morvan, F-54511, V
198
Aneurysm of the Internal Carotid Artery Misdiagnosed as Cervical Paraganglioma; A Case Report and Literature Review
199
Aneurysm of the left atrial appendage
200
Aneurysm of the left pulmonary artery: surgical allograft repair
201
Aneurysm of the Left Sinus of Valsalva Producing Aortic Valve Regurgitation and Myocardial Ischemia
202
Aneurysm of the membranous interventricular septum demonstrated by multislice computed tomography
203
Aneurysm of the membranous ventricular septum resulting in pulmonary outflow tract obstruction in congenitally corrected transposition of the great arteries, ,
204
Aneurysm of the Mitral Valve: A Rare Complication of Aortic Valve Endocarditis
205
Aneurysm of the Pulmonary Artery in Fallot’s Tetralogy
206
Aneurysm of the right renal vein arising from an idiopathic arteriovenous fistula
207
Aneurysm shrinkage after endovascular repair of aortic diseases
208
Aneurysm Surgery: Step by Step to Meet the God
209
Aneurysmal Aorto-Left Ventricular Tunnel
210
Aneurysmal Bone Cyst after Femoral Derotational Osteotomy: A Case Report
211
Aneurysmal Bone Cyst in the First Rib
212
Aneurysmal Bone Cyst of Sphenoid Bone-A Case Report
213
Aneurysmal Bone Cyst of the Capitate: A rare case report
214
Aneurysmal bone cyst of the orbit: A case of rare location and review of the literature
215
Aneurysmal bone cyst originating from the first rib
216
Aneurysmal bone cyst with chromosomal changes involving 7q and 16p
217
Aneurysmal Bone Cyst: An Analysis of 38 Cases and Report of Four Unusual Surface Ones
218
Aneurysmal Bone Cyst: An Analysis of 38 Cases and Report of Four Unusual Surface Ones
219
Aneurysmal bone cyst-like areas as a sign of metastatic disease in the spinal column
220
Aneurysmal change in an internal mammary artery–pulmonary artery fistula
221
Aneurysmal Dilatation of the Contegra Bovine Jugular Vein Conduit After Reconstruction of the Right Ventricular Outflow Tract
222
Aneurysmal femoral neck cyst: Report of a paediatric case and review of literature
223
Aneurysmal pericardial patch producing right ventricular inflow obstruction
224
Aneurysmal rebleeding episode after lumbar puncture
225
Aneurysmal wall calcification predicts natural history of small abdominal aortic aneurysms
226
Aneurysmal walls in unruptured intracranial aneurysms
227
Aneurysmosis presenting as acute limb ischemia
228
Aneurysms After Coarctation Repair Associated With Hypoplastic Aortic Arch: Surgical Management Through Median Sternotomy
229
Aneurysms and Aortic Insufficiency: Two Very Rare Complications of Wilson’s Disease
230
Aneurysms complicating pulmonary autograft procedure for aortic valve replacement
231
Aneurysms of Sinus of Valsalva
232
Aneurysms of the portal venous system: Gray-scale and color doppler ultrasonographic findings with CT and mri correlation
233
Aneurysms of the Sinus of Valsalva in a Patient with Behcet's Disease
234
Aneurysms unsuitable for endovascular intervention: Surgical outcome and management challenges over a 5-year period following International Subarachnoid Haemorrhage Trial (ISAT)
235
Aneusomy detection by fluorescence in situ hybridization (FISH) using bladder washings: correlation with cytology, cytogenetics and clinical features predicts recurrence and defines test limitations
236
Aneusomy for detection of bladder cancer recurrence: a Southwest Oncology Group study
237
Aneutronics–thermalhydraulicsmodelforpreliminarystudiesonTRADEdynamicsOriginalResearchArticle
238
AnevaluationofreactorcoolingandcoupledhydrogenproductionprocessesusingthemodularheliumreactorOriginalResearchArticle
239
Anevaluationofriskmethodsforprioritizingfireprotectionfeatures:aprocedureforfirebarrierpenetrationsealsOriginalResearchArticle
240
ANew Algorithm to Impute the MissingValues in the Multivariate Case
241
ANew Low-Temperature Preparations of Some Simple and Mixed Co and Ni Dispersed Sulfides and Their Chemical Behavior in Reducing Atmosphere
242
ANew Scheme for Storage and Retrieval of Shared Text Files
243
Anewapproachtodesigningreducedscalethermal-hydraulicexperimentsOriginalResearchArticle
244
A-New-Closed-form-Mathematical-Approach-to-Achieve Minimum Phase Noise in Frequency Synthesizers
245
AnewfinitecloudmethodforcalculatingexternalexposuredoseinanuclearemergencyOriginalResearchArticle
246
AnewLMRsteamgeneratorfreefromSWRwithadoubletubebundleconfigurationOriginalResearchArticle
247
Anewphenomenologicalcriterionforpellet–claddinginteractionruptureOriginalResearchArticle
248
AnewversionofthereflectedcoreinhourequationanditssolutionOriginalResearchArticle
249
AnexperimentalandanalyticalstudyoftheeffectofaxialpowerprofileonCHFOriginalResearchArticle
250
AnexperimentalinvestigationonthecriticalheatfluxenhancementbymechanicalvibrationinverticalroundtubeOriginalResearchArticle
251
AnexperimentalstudyonquenchingofaradiallystratifiedheatedporousbedOriginalResearchArticle
252
Anexperimentalstudyonthecriticalheatfluxforlowflowofwaterinanon-uniformlyheatedverticalrodbundleoverawiderangeofpressureconditionsOriginalResearchArticle
253
AnexperimentalvalidationoftheguidelineforinelasticdesignanalysisthroughstructuralmodeltestsOriginalResearchArticle
254
AnF1-Module for the 3U4(3)-Amalgam Original Research Article
255
AnF1-Module for the 3U4(3)-Amalgam Original Research Article
256
Anfälle. Erfahrungen mit Epilepsie. Edited by Stefan Heiner, Margret Meyer-Brauns, and Lotte Habermann-Horstmeier
257
ANFIS and statistical based approach to prediction the peak pressure load of concrete pipes including glass fiber
258
ANFIS based Distillation Column Control
259
ANFIS Based Modeling of the Hormonal Effects of GLP-2 on the Mean Arterial Pressure and Blood Volume of Rats
260
ANFIS Controller for Non-holonomic Robots
261
ANFIS Controller for Non-holonomic Robots
262
ANFIS for high-pressure waterjet cleaning prediction
263
ANFIS modeling and validation of a variable speed wind turbine based on actual data
264
ANFIS Modeling to Forecast Maintenance Cost of Associative Information Technology Services
265
ANFIS Modelling of Carbon and Nitrogen Removal in Domestic Wastewater Treatment Plant
266
ANFIS modelling of the performance and emissions of a diesel engine using diesel fuel and biodiesel blends
267
ANFIS Speed Controller of IM Drives with Three-level DTC-based Neural Network
268
ANFIS-Based Diagnosis and Location of Stator Interturn Faults in PM Brushless DC Motors
269
ANFIS-based estimation of PV module equivalent parameters: application to astand-alone PV system with MPPT controller
270
ANG II activates P38 MAP kinase and ERK1/2, but not JNK, in vascular smooth muscle cells from SHR
271
Ang II-stimulated generation of reactive oxygen species in human vascular smooth muscle cells is mediated via PLD-dependent pathways
272
Angel investors and the market for angel investments
273
Angel Rain (Tishtar): Case Study of Boghe of Gilan and Saghanefars of Mazandaran
274
Angel, handmaiden, battleaxe or whore? A study which examines changes in newly recruited student nurses’ attitudes to gender and nursing stereotypes
275
Angela Carter’s Heroes and Villains: A Dystopian Romance
276
Angelic machines: A philosophical dialogue (2)
277
Angelic semantics of fine-grained concurrency
278
Angelica archengelica extract induced perturbation of rat skin and tight junctional protein (ZO-1) of HaCaT cells
279
Angelica stimulates proliferation of murine bone marrow mononuclear cells by the MAPK pathway
280
Angelicae Gigantis Radix regulates mast cell-mediated allergic inflammation in vivo and in vitro
281
Angelman Syndrome: A Case Report
282
Angelman syndrome: a review of clinical and genetic aspects
283
Angelman Syndrome: Finding the Lost Arc
284
Angelman syndrome: is there a characteristic EEG?
285
Angelmarin, a novel anti-cancer agent able to eliminate the tolerance of cancer cells to nutrient starvation
286
Angelo Peccerillo, Plio-Quaternary volcanism in Italy: Petrology, geochemistry, geodynamics,
287
Angelonia flower mottle, a new disease of Angelonia angustifolia caused by a hitherto unknown carmovirus
288
Angels and spirits in the world of illness
289
Angels in the details: Comment on “The relationship between destination proximity, destination mix and physical activity behaviors”
290
Anger and aggression among drivers in three European countries
291
Anger- and aggression-related traits are associated with polymorphisms in the 5-HT-2A gene
292
Anger and anger expression in relation to perceptions of social rank, entrapment and depressive symptoms
293
Anger and blood pressure readings in children
294
Anger and Gender Effects in Observed Supervisor-Subordinate Dyadic Interactions
295
Anger and hostility in adolescents: Relationships with self-reported attachment style and perceived parental rearing styles
296
Anger and hostility in maritally violent men: Conceptual distinctions, measurement issues, and literature review
297
Anger and hostility linked to coronary heart disease
298
Anger and impulsivity in non-clinical women
299
Anger and inhibitory control as moderators of childrenʹs hostile attributions and aggression
300
Anger and inhibitory control as moderators of childrenʹs hostile attributions and aggression
301
Anger and Irritability Symptoms among Youth with ODD: Cross-Informant Versus Source-Exclusive Syndromes
302
Anger and personality in eating disorders
303
Anger and psychopathology in prison inmates
304
Anger and somatization
305
Anger and the behavioral approach system
306
Anger as a cue to truthfulness
307
Anger as a Psychological Risk Factor of Hypertension
308
Anger assessment with the STAXI-CA: psychometric properties of a new instrument for children and adolescents
309
Anger at graphic evidence at Omagh inquest
310
Anger at US transplant waiting times “scare”
311
Anger Attacks in Major Depressive Disorder and Serum Levels of Homocysteine
312
Anger expression and essential hypertension: Behavioral response to confrontation
313
Anger expression in children and adolescents: A review of the empirical literature
314
Anger expression in Swiss adolescents: Establishing measurement invariance across gender in the AX scales
315
Anger expression, coping, and substance use in adolescent offenders
316
Anger expression, partner support, and quality of life in cancer patients
317
Anger in Adolescent Boy Athletes: a Comparison among Judo, Karate, Swimming and Non Athletes
318
Anger in chronic pain: Investigations of anger targets and intensity
319
Anger in healthy men: a PET study using script-driven imagery
320
Anger in prisoners: women are different from men
321
Anger in the Trajectory of Healing From Childhood Maltreatment
322
Anger in UK as discredited doctor is elected to doctorsʹ ruling body
323
Anger induced by interferon-alpha is moderated by ratio of arachidonic acid to omega-3 fatty acids
324
Anger Management among Medical Undergraduate Students and Its Impact on Their Mental Health and Curricular Activities
325
Anger Management and Control in Social and Behavioral Sciences: A Systematic Review of Literature on Biopyschosocial Model
326
Anger Management and Factors that Influence Anger in Physicians
327
Anger Management May Save Your Life: New Insights Into Emotional Precipitants of Ventricular Arrhythmias
328
Anger management style and the prediction of treatment outcome among male and female chronic pain patients
329
Anger on ruling not to prosecute Irish doctors
330
Anger over dangerous withdrawal of antipsychotics from Pakistan
331
Anger over handling of Madagascarʹs cholera epidemic
332
Anger response styles and reaction to provocation
333
Anger rumination in Hong Kong and Great Britain: Validation of the scale and a cross-cultural comparison
334
Anger scale and anger types of patients with fifth metacarpal neck fracture
335
Anger scale and anger types of patients with fifth metacarpal neck fracture
336
Anger superiority effect for change detection and change blindness
337
Anger suppression mediates the relationship between optimism and natural killer cell cytotoxicity in men treated for localized prostate cancer
338
Anger symptoms and “delinquent” behavior in Tourette syndrome with and without attention deficit hyperactivity disorder
339
Anger types and the use of cigarettes and smokeless tobacco among Native American adolescents
340
Anger, aggression, and risky behavior: a comparison of high and low anger drivers
341
Anger, aggression, risky behavior, and crash-related outcomes in three groups of drivers
342
Anger, Anger Expression, and Suicidal Ideation in Korean Adolescents
343
Anger, Depression, and Anxiety in Cardiac Patients: The Complexity of Individual Differences in Psychological Risk
344
Anger, depression, and coping interactions in headache activity and adjustment: a controlled study
345
Anger, hostility, and male perpetrators of intimate partner violence: A meta-analytic review
346
Anger, negative emotions, and cardiovascular reactivity during interpersonal conflict in women
347
Anger, over-control and serious violent offending
348
Anger, psychopathology and cognitive inhibition: a study of UK servicemen
349
Anger, Suppressed Anger, and Risk of Adverse Events in Patients With Coronary Artery Disease
350
Anger-associated panic attacks in Cambodian refugees with PTSD; a multiple baseline examination of clinical data
351
Anger-in and hostility in myocardial infarction patients
352
Anger-Induced T-Wave Alternans Predicts Future Ventricular Arrhythmias in Patients With Implantable Cardioverter-Defibrillators
353
Angerlike behavioral state potentiates myocardial ischemia-induced T-wave alternans in canines
354
Anggaran dan Ciri Fizikokimia Sisa Buangan Makanan di Bandar Baru Bangi
355
angian lattice boltzmann method for euler equati
356
Angina 1 year after percutaneous coronary intervention: A report from the NHLBI Dynamic Registry
357
Angina and origin of three major coronary arteries from independent ostia in right coronary sinus
358
Angina and sudden cardiac death caused by anomalous right coronary artery origin from above the left coronary cusp
359
Angina bullosa hemorrhagica: an idiopathic intraoral blistering disorder
360
Angina caused by coronary steal phenomenon
361
Angina caused by systolic compression of the left coronary artery as a result of pseudoaneurysm of the mitral-aortic intervalvular fibrosa
362
Angina for 14 years
363
Angina Pectoris and Atherosclerotic Risk Factors in the Multisite Cardiac Lifestyle Intervention Program
364
Angina pectoris and myocardial infarction with the use of leuprolife acetate
365
Angina pectoris caused by coronary microvascular spasm
366
Angina pectoris caused by microvascular spasm
367
Angina pectoris caused by microvascular spasm
368
Angina Pectoris or Myocardial Infarctions, Pulmonary Arteriovenous Malformations, Hereditary Hemorrhagic Telangiectasia, and Paradoxical Emboli
369
Angina pectoris prior to myocardial infarction protects against subsequent left ventricular remodeling Original Research Article
370
Angina pectoris: a headache
371
Angina reassessed: pain or protector?
372
Angina Self-Management Plan and Quality of Life, Anxiety and Depression in Post Coronary Angioplasty Patients
373
Angina symptoms in men and women with stable coronary artery disease and evidence of exercise-induced myocardial perfusion defects
374
Angina-Induced Protection Against Myocardial Infarction in Adult and Elderly Patients: Loss of Preconditioning Mechanism in the Aging Heart?
375
Anginal Status and Prediction of Cardiac Events in Patients Enrolled in the Asymptomatic Cardiac Ischemia Pilot (ACIP) Study
376
Anginal symptoms consistently predict total mortality among outpatients with coronary artery disease
377
Angioarchitecture and blood circulation in focal nodular hyperplasia of the liver
378
Angioarchitecture of monochorionic placentas in relation to the twin-twin transfusion syndrome
379
Angioarrestin mRNA expression in early-stage lung cancers
380
Angio-Associated Migratory Cell Protein and Smooth Muscle Cell Migration in Development of Restenosis and Atherosclerosis
381
Angioblasts in peripheral blood
382
Angiocardiographic findings in patients with biphasic T-wave inversion in precordial leads
383
Angiocardiography and magnetic resonance imaging to assess pulmonary regurgitation in repaired tetralogy of Fallot
384
Angiocentric Nasal T-Cell Lymphoma in a Patient with Idiopathic CD4+ Lymphocytopenia
385
Angiodysplasia: New Look at an Old Conundrum
386
Angiodysplastic lesions as a cause of colonic bleeding in patients with chronic renal disease: is there an association?
387
Angioedema and urticaria as early presentations of a COVID-19 patient: a case report
388
Angioedema Associated With Droperidol Administration, , ,
389
Angioedema Associated with Haloperidol
390
Angioedema associated with sumatriptan administration
391
Angioedema due to acquired C1-inhibitor deficiency: A bridging condition between autoimmunity and lymphoproliferation
392
Angioedema Due to Lamiaceae Allergy
393
Angioedema Due to Lamiaceae Allergy
394
Angioedema in a Patient with C1 Esterase Inhibitor Deficiency
395
Angioedema related to the ue of hyaluronidae in cataract urgery
396
Angioedema. Interdisciplinary diagnostic and therapeutic recommendations of the Polish Dermatological Society (PTD) and Polish Society of Allergology (PTA)
397
Angioembolization as an effective alternative for hemostasis in intractable life-threatening maxillofacial trauma hemorrhage: case study
398
Angioembolization in itractable epistaxis — a tertiary care experience
399
Angioemboliziation of Internal Pudendal Artery for Treatment of Long Lasting Gross Hematuria After Transurethral Resection of the Prostate
400
Angiofibroma of the Nasal Septum
401
Angiofollicular lymph node hyperplasia (Castlemanʹs disease)
402
Angiogenèse et radiothérapie : tout ce qu’un oncologue radiothérapeute doit savoir
403
Angiogenesis and anti-angiogenesis in hepatocellular carcinoma
404
Angiogenesis and antiangiogenic therapy in hepatocellular carcinoma
405
Angiogenesis and breast cancer
406
Angiogenesis and breast cancer metastasis
407
Angiogenesis and chronic disease
408
Angiogenesis and functional recovery demonstrated after minor stroke
409
Angiogenesis and growth factor expression in a model of transmyocardial revascularization
410
Angiogenesis and growth factor modulation induced by alternagin C, a snake venom disintegrin-like, cysteine-rich protein on a rat skin wound model
411
Angiogenesis and hepatocellular carcinoma
412
Angiogenesis and intrauterine growth restriction
413
Angiogenesis and Its Targeting in Glioblastoma with Focus on Clinical Approaches
414
Angiogenesis and Mast Cells Density in Oral and Esophageal Squamous Cell Carcinomas
415
Angiogenesis and Minimal Residual Disease in Patients with Acute Myeloid Leukemia
416
Angiogenesis and molecular biologic substaging in patients with stage I non—small cell lung cancer
417
Angiogenesis and Morphometry of Bovine Placentas in Late Gestation from Embryos Produced In Vivo or In Vitro
418
Angiogenesis and musculogenesis as two facets of inflammatory post-ischemic tissue regeneration
419
Angiogenesis and Nitric Oxide in Elderly Men after Continuous and Interval Aerobic Training
420
Angiogenesis and placental growth in normal and compromised pregnancies
421
Angiogenesis and Tumor-Associated Macrophages in Different Grades of Oral Squamous Cell Carcinoma, Verrucous Carcinoma and Epithelial Dysplasia via Immunohistochemical Assessment of Expression of CD34 and CD68 Markers
422
Angiogenesis and vascular endothelial growth factor expression in the equine corpus luteum
423
Angiogenesis as targeted breast cancer therapy
424
Angiogenesis assays
425
ANGIOGENESIS EFFECTS OF CHINESE HERBAL SALVIA MILTIORRHIZA AFTER ACUTE MYOCARDIAL INFARCTION IN RATS
426
Angiogenesis factor in endometrial carcinoma: A new prognostic indicator?, ,
427
Angiogenesis Following Three-Dimensional Culture of Isolated Human Endometrial Stromal Cells
428
Angiogenesis Following Three-Dimensional Culture of Isolated Human Endometrial Stromal Cells
429
Angiogenesis in bone fracture healing: A bioregulatory model
430
Angiogenesis in cervical intraepithelial neoplasia and the risk of recurrence, ,
431
Angiogenesis in chronic myelogenous leukaemia
432
Angiogenesis in chronic myelogenous leukaemia
433
Angiogenesis in colon hyperplastic polyp
434
Angiogenesis in ductal breast carcinoma and its correlation with the prognostic parameters
435
Angiogenesis in ductal breast carcinoma. Comparison of microvessel density between primary tumour and lymph node metastasis
436
Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation
437
Angiogenesis in ischemic human myocardium: clinical results after 3 years
438
Angiogenesis in Ischemic Stroke Patients Aged 30 - 80 years at Gatot Subroto Army Central Hospital (RSPAD) Jakarta
439
Angiogenesis in neovascularized free muscle grafts
440
Angiogenesis in odontogenic keratocyst and dentigerous cyst: Evaluation of JunB and VEGF expression
441
ANGIOGENESIS IN OPEN TIBIAL FRACTURES: A COMPARISON OF MUSCLE AND FASCIOCUTANEOUS FLAPS
442
Angiogenesis in ovarian cancer
443
Angiogenesis in ovarian follicular and luteal development
444
Angiogenesis in primary and metastatic epithelial ovarian carcinoma, ,
445
Angiogenesis in Rat Ischemic Hindlimb: Role of Human Bone Marrow-Derived Mesenchymal Stem Cells Transplantation
446
Angiogenesis in the Pathobiology and Treatment of Vascular and Malignant Diseases
447
ANGIOGENESIS IN TISSUE ENGINEERING
448
Angiogenesis in transmyocardial revascularization: comparison of laser versus mechanical punctures
449
Angiogenesis induced by autologous whole bone marrow stem cells seeded on collagen scaffolds in silicone nerve tubes. An experimental study
450
Angiogenesis induced by urothelial cells (HCV-29) and their v-ras and v-raf transfectants
451
Angiogenesis inhibition plus chemotherapy for metastatic hormone refractory prostate cancer: History and rationale
452
Angiogenesis inhibitor DC101 delays growth of intracerebral glioblastoma but induces morbidity when combined with irradiation
453
Angiogenesis inhibitor TX-1898: syntheses of the enantiomers of sterically diverse haloacetylcarbamoyl-2-nitroimidazole hypoxic cell radiosensitizers Original Research Article
454
Angiogenesis inhibitors derived from thalidomide
455
Angiogenesis Is Enhanced in Ischemic Canine Myocardium by Transmyocardial Laser Revascularization
456
Angiogenesis markers (VEGF, soluble receptor of VEGF and angiopoietin-1) in very early arthritis and their association with inflammation and joint destruction
457
Angiogenesis modulatory activity of SC-CO2 leaf extract of guyabano (Annona muricata Linn.) using chick embryo chorioallantoic membrane assay
458
Angiogenesis of the ovary,
459
Angiogenesis Status in Patients with Acute Myeloid Leukemia: From Diagnosis to Post-hematopoietic Stem Cell Transplantation
460
Angiogenesis with recombinant fibroblast growth factor-2 for claudication
461
Angiogenesis with recombinant fibroblast growth factor-2 for claudication
462
ANGIOGENESIS WITHIN ATHEROSCLEROTIC LESIONS BY STEM/PROGENITOR CELLS
463
Angiogenesis, Arteriogenesis, and Diabetes: Paradigm Reassessed?
464
Angiogenesis, myogenesis and cell therapy I
465
Angiogenesis, Myogenesis, and Cell Therapies
466
Angiogenesis, tumor necrosis factor-α and procoagulant factors in coronary artery giant aneurysm of a fatal infantile Kawasaki disease
467
Angiogenesis/myogenesis cell therapy
468
Angiogenesis/myogenesis/cell therapy II
469
Angiogenesis: A Critical Role in Locally Aggressive Behavior of Keratocystic Odontogenic Tumor
470
Angiogenic activitiy of syndecan-binding laminin peptide AG73 (RKRLQVQLSIRT)
471
Angiogenic activity in the sera of patients with post-kidney transplant erythrocytosis
472
Angiogenic and inflammatory response to biodegradable scaffolds in dorsal skinfold chambers of mice
473
Angiogenic Effect of Leptin in the Quail Chorioallantoic Membrane
474
Angiogenic effect of naive and 5-fluorouracil resistant colon carcinoma on endothelial cells in vitro
475
Angiogenic effect of prostaglandin I 2 in relation with its effect on PPAR nuclear receptors
476
Angiogenic effect of the aqueous extract of Cynodon dactylon on human umbilical vein endothelial cells and granulation tissue in rat
477
ANGIOGENIC EFFECTS OF A NEW HMG-COA REDUCTASE INHIBITOR, PITAVASTATIN
478
Angiogenic Effects of Aerobic Training and Royal Jelly Consumption with Emphasis on the Role of miR-126 and miR-210 in the Aortic Artery of Ovariectomized Diabetic Rats
479
Angiogenic factors and the risk of preeclampsia: A systematic review and meta-analysis
480
Angiogenic factors in chronic liver diseases: the effects on hepatic progenitor cells
481
Angiogenic gene therapy with adenovirus 5 fibroblast growth factor-4 (Ad5FGF-4): a new option for the treatment of coronary artery disease
482
Angiogenic growth factors in human dentine matrix
483
Angiogenic growth factors released in human dental pulp following orthodontic force
484
Angiogenic induction and cell migration in an orthopaedically expanded maxillary suture in the rat
485
Angiogenic output in viral hepatitis, C and B, and HCV-associated hepatocellular carcinoma
486
Angiogenic response induced by acellular femoral matrix in vivo
487
Angiogenic responses are enhanced in mechanically and microscopically characterized, microbial transglutaminase crosslinked collagen matrices with increased stiffness
488
Angiogenic signal triggered by ischemic stress induces myocardial repair in rat during chronic infarction
489
Angiogenic therapy of acute myocardial infarction by intrapericardial injection of basic fibroblast growth factor and heparin sulfate: An experimental study
490
Angiogenin and osteopontin and coronary collateral circulation
491
Angiogenin plasma levels during pregnancy
492
Angiogenin: A marker for preterm delivery in midtrimester amniotic fluid, , , ,
493
Angiograph image restoration with the use of rule base fuzzy 2D Kalman filter
494
Angiographic 5-year follow-up study of right gastroepiploic artery grafts
495
Angiographic Adverse Events, Creatine Kinase-MB Elevation, and Ischemic End Points Complicating Percutaneous Coronary Intervention (a REPLACE-2 Substudy)
496
Angiographic Analysis of Pattern of Late Luminal Loss in Sirolimus- and Paclitaxel-Eluting Stents
497
Angiographic Analysis of the Anatomic Relation of Coronary Arteries to Mitral and Tricuspid Annulus and Implications for Radiofrequency Ablation
498
Angiographic analysis of the angioplasty versus rotational atherectomy for the treatment of diffuse in-stent restenosis trial (ARTIST)
499
Angiographic anatomical variation of origin of left circumflex coronary artery in Basrah
500
Angiographic anatomy of the grafted left internal mammary artery
501
Angiographic and clinical characteristics associated with increased in-hospital mortality in elderly patients with acute myocardial infarction undergoing percutaneous intervention (a pooled analysis of the primary angioplasty in myocardial infarction tria
502
Angiographic and clinical characteristics associated with the development of q-wave and non-q–wave myocardial infarction in the thrombolysis in myocardial infarction (timi) 14 trial
503
Angiographic and clinical outcome following coronary stenting of small vessels : comparison with coronary stenting of large vessels
504
Angiographic and clinical outcome of mild to moderate nonocclusive unstented coronary artery dissection and the influence on coronary flow velocity reserve
505
Angiographic and clinical outcomes associated with direct versus conventional stenting among patients treated with fibrinolytic therapy for ST-elevation acute myocardial infarction
506
Angiographic and clinical outcomes following acute infarct angioplasty on saphenous vein grafts
507
Angiographic and clinical outcomes of late total occlusion versus treatment failure without late total occlusion in patients after intracoronary radiation therapy for in-stent restenosis
508
Angiographic and clinical outcomes of polytetrafluoroethylene-covered stent use in significant coronary perforations
509
Angiographic and Interventional Radiological Management of Obscure Overt Gastrointestinal Bleeding
510
Angiographic and intravascular ultrasound predictors of in-stent restenosis
511
Angiographic and intravascular ultrasound study of the effects of overlapping sirolimus- and paclitaxel-eluting stents: Comparison with same drug-eluting overlapping stents
512
Angiographic and Magnetic Resonance Imaging Evaluation of In-Hospital Delay in Primary Percutaneous Intervention Delivery on Myocardial Salvage
513
Angiographic and morphologic features of the left ventricle in Ebsteinʹs malformation
514
Angiographic and procedural outcome after coronary angioplasty in high-risk subsets using a decremental diameter (tapered) balloon catheter
515
Angiographic and prognostic implications of an exaggerated exercise systolic blood pressure response and rest systolic blood pressure in adults undergoing evaluation for suspected coronary artery disease
516
Angiographic and three-dimensional intravascular ultrasound analysis of combined intracoronary beta radiation and self-expanding stent implantation in human coronary arteries
517
Angiographic and volumetric intravascular ultrasound comparison between direct Sirolimus-Eluting stent implantation versus predilation
518
Angiographic aspects of ruptured plaque in patients with acute myocardial infarction: correlation with clinical and laboratory variables
519
Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients
520
Angiographic assessment of myocardial perfusion in patients with isolated coronary artery ectasia
521
Angiographic changes in saphenous vein grafts are predictors of clinical outcomes
522
Angiographic changes in vein grafts: Stable surrogate or seductive siren?
523
Angiographic Characteristics of Coronary Disease and Postresuscitation Electrocardiograms in Patients With Aborted Cardiac Arrest Outside a Hospital
524
Angiographic characteristics of infarct-related and non-infarct-related stenoses in patients in whom stable angina progressed to acute myocardial infarction, ,
525
Angiographic complications in CADASIL
526
Angiographic complications of primary angioplasty
527
Angiographic coronary artery disease associated with hypertensive heart failure and normal ejection fraction. Insights from a prospective monocenter study
528
Angiographic correlates of “spotty” coronary artery calcium detected by electron-beam computed tomography in patients with normal or near-normal coronary angiograms
529
Angiographic correlates of cardiac death and myocardial infarction complicating major nonthoracic vascular surgery
530
Angiographic Correlates of Graft Patency and Relationship to Clinical Outcomes
531
Angiographic correlates of lesion relevance and suitability for percutaneous transluminal coronary angioplasty and coronary artery bypass grafting in the bypass angioplasty revascularization investigation study (BARI)
532
Angiographic deterioration of target coronary artery narrowing as a result of percutaneous balloon angioplasty, ,
533
Angiographic embolization for arrest of bleeding after penetrating trauma to the abdomen
534
Angiographic Embolization of a Traumatic Pulmonary Pseudoaneurysm
535
Angiographic Evaluation of Myocardial Perfusion in Patients With Syndrome X
536
Angiographic evaluation of the effect of intracoronary abciximab administration in patients undergoing urgent PCI
537
Angiographic evaluation of traumatic arterial injuries of the upper limbs: a retrospective study
538
Angiographic Evolution of Intracoronary Thrombus and Dissection Following Percutaneous Transluminal Coronary Angioplasty (The Thrombolysis and Angioplasty in Unstable Angina [TAUSA] Trial)
539
Angiographic Fate of Collateral Vessels After Surgical Revascularization of the Totally Occluded Left Anterior Descending Artery
540
Angiographic Features and Cardiovascular Risk Factors in Human Immunodeficiency Virus-Infected Patients With First-Time Acute Coronary Syndrome
541
Angiographic features of vein grafts versus ungrafted coronary arteries in patients with unstable angin and previous bypass surgery
542
Angiographic features, surgical management and outcomes of proximal middle cerebral artery aneurysms
543
Angiographic findings and clinical correlates in patients with cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry
544
Angiographic Findings and Outcome in Diabetic Patients Treated With Thrombolytic Therapy for Acute Myocardial Infarction: The GUSTO-I Experience
545
ANGIOGRAPHIC FINDINGS IN 130 PATIENTS WITH ANEURYSMAL SUBARACHNOID HEMORRHAGE
546
Angiographic findings in Buerger disease
547
Angiographic findings in monozygotic twins with coronary artery disease
548
Angiographic findings in patients undergoing catheterization for recurrent symptoms within 30 days of successful coronary intervention
549
Angiographic findings in tumoral calcinosis
550
Angiographic Findings of Patients with Blunt or Penetrating Extremity Injuries: Focus on Indications and Contraindications
551
Angiographic Findings, Time Course of Regional and Global Left Ventricular Function, and Clinical Outcome in Diabetic Patients With Acute Myocardial Infarction Treated With Primary Percutaneous Transluminal Coronary Angioplasty
552
Angiographic Follow-up of Internal Thoracic Artery for Free Bypass Grafting
553
Angiographic follow-up results of STent versus Atherectomy Randomized Trial (START)
554
Angiographic Lesion Severity and Subsequent Myocardial Infarction
555
Angiographic Localization of Potential Culprit Coronary Arteries in Patients With Interatrial Block Following a Positive Exercise Tolerance Test
556
Angiographic methods to assess human coronary angiogenesis
557
Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction
558
Angiographic Outcomes With Early Eptifibatide Therapy in Non–ST-Segment Elevation Acute Coronary Syndrome (from the EARLY ACS Trial)
559
Angiographic Patency of the Radial Artery Conduit in Coronary Artery Bypass Grafting
560
Angiographic Pattern of Restenosis Following Implantation of Overlapping Sirolimus-Eluting (Cypher) Stents
561
Angiographic Patterns of Drug-Eluting Stent Restenosis and One-Year Outcomes After Treatment With Repeated Percutaneous Coronary Intervention
562
Angiographic patterns of restenosis after paclitaxel-eluting stent implantation
563
Angiographic perfusion score: An angiographic variable that integrates both epicardial and tissue level perfusion before and after facilitated percutaneous coronary intervention in acute myocardial infarction
564
Angiographic plaque complexity: the tip of the unstable plaque iceberg
565
Angiographic Predictors and Clinical Outcome of Acute Side Branch Occlusion after Coronary Artery Stent Implantation
566
Angiographic Predictors of 6-Month Patency of Bypass Grafts Implanted to the Right Coronary Artery: A Prospective Randomized Comparison of Gastroepiploic Artery and Saphenous Vein Grafts Original Research Article
567
Angiographic predictors of adverse outcomes in the modern interventional era
568
Angiographic predictors of graft patency and disease progression after coronary artery bypass grafting with arterial and venous grafts
569
Angiographic predictors of neointimal thickening after successful coronary wall healing following percutaneous revascularization
570
Angiographic predictors of new coronary occlusions
571
Angiographic Predictors of Recurrent Stent Thrombosis (from the Outcome of PCI for Stent-ThrombosIs MultIcentre STudy [OPTIMIST])
572
Angiographic predictors of reocclusion after thrombolysis: Results from the thrombolysis in myocardial infarction (TIMI) 4 trial
573
Angiographic presence of myocardial bridge after successful percutaneous transluminal coronary angioplasty
574
Angiographic presentation of coronary artery spasm in heart transplant recipients
575
Angiographic profile in patients with congenital anomalous origin of the coronary arteries
576
Angiographic restenosis rate in patients with chronic total occlusions and subtotal stenoses after initially successful intracoronary stent placement
577
Angiographic results after the use of a sutureless aortic connector for proximal vein graft anastomoses
578
Angiographic results of the first human experience with everolimus-eluting stents for the treatment of coronary lesions (the FUTURE I trial)
579
Angiographic Results of the First Human Experience With the Biolimus A9 Drug-Eluting Stent for De Novo Coronary Lesions
580
Angiographic right and left ventricular function in arrhythmogenic right ventricular dysplasia
581
Angiographic severity and extent of coronary artery disease in patients with type 1 diabetes mellitus
582
Angiographic severity and extent of coronary artery disease in type 1 diabetes
583
Angiographic severity of coronary artery disease in patients with metabolic syndrome
584
Angiographic severity of coronary narrowing is a surrogate marker for the extent of coronary atherosclerosis
585
Angiographic significance of a discordant ST-segment elevation of ≥5 millimeters in patients with ventricular-paced rhythm and acute myocardial infarction
586
Angiographic Stent Thrombosis After Routine Use of Drug-Eluting Stents in ST-Segment Elevation Myocardial Infarction: The Importance of Thrombus Burden Original Research Article
587
Angiographic study of aorta, coronary arteries, and left ventricular performance after neonatal arterial switch operation for simple transposition of the great arteries, ,
588
Angiographic study of Moyamoya disease and histological study in the external carotid artery system
589
Angiographic Surrogate End Points in Drug-Eluting Stent Trials: A Systematic Evaluation Based on Individual Patient Data From 11 Randomized, Controlled Trials Original Research Article
590
Angiographic variables predict increased riskfor adverse ischemic events after coronarystenting with glycoprotein IIb/IIIa inhibition: Results from the TARGET trial
591
Angiographic Versus Functional Severity of Coronary Artery Stenoses in the FAME Study: Fractional Flow Reserve Versus Angiography in Multivessel Evaluation
592
Angiographic, intravascular ultrasound and functional findings early after orthotopic heart transplantation
593
Angiographic, ultrasonic, and angioscopic assessment of the coronary artery wall and lumen area configuration after directional atherectomy: The mechanism revisited
594
Angiographical and computed tomographic findings in diffuse pulmonary arteriovenous fistulas
595
Angiographical study of ramus intermedius coronary artery in Basrah
596
Angiographically assessed coronary collateral circulation increases vulnerability to myocardial ischemia during vasodilator stress testing
597
Angiographically evident atherosclerotic stenosis associated with myocardial bridging and risk factors for the artery stenosis located proximally to myocardial bridging
598
Angiographically silent atherosclerosis detected by intravascular ultrasound in patients with familial hypercholesterolemi and familial combined hyperlipidemia: Correlation with high density lipoproteins
599
Angiographically silent left main disease detected by intravascular ultrasound: a marker for future adverse cardiac events
600
Angiography and arterial stimulation venous sampling in the localization of pancreatic neuroendocrine tumours
601
Angiography and interventional cardiology
602
Angiography and interventional cardiology Review Article
603
Angiography and revascularization in patients with heart failure following fibrinolytic therapy for ST-elevation acute myocardial infarction
604
Angiography of potential cardiac donors
605
Angiography versus intravascular ultrasound assessment of coronary stent placement: observations from the AVID study
606
Angiography; an Inducer of TGF-Β during Early Atherosclerosis
607
Angiography-proven liver metastases explain low efficacy of lymph node dissections in medullary thyroid cancer patients
608
Angiography-proven liver metastases explain low efficacy of lymph node dissections in medullary thyroid cancer patients
609
Angioid streaks and other ocular complications of Pagetʹs disease of bone
610
Angioimmunoblastic lymphadenopathy-like T-cell lymphoma A case report and immunologic study
611
Angiokeratoma corporis diffusum without systemic features in a young Kashmiri female: a rare occurrence
612
Angioleiomyoma in the tonsil: an uncommon tumour in a rare site
613
Angioleiomyoma of the diaphragm
614
Angioleiomyoma of the Hand: A Case Series and Review of the Literature
615
Angioleiomyoma: a benign tumor with karyotypic aberrations
616
Angiolipoma of the breast with microcalcification: Mammographic, sonographic, and histologic appearances
617
Angiolymphoid hyperplasia with eosinophilia
618
Angiolymphoid hyperplasia with eosinophilia
619
ANGIOLYMPHOID HYPERPLASIA WITH EOSINOPHILIA – A RARE ENTITY
620
Angioma serpiginosum successfully treated by a single session of intense pulsed light therapy
621
Angiomagnetic resonance imaging of iliofemorocaval venous thrombosis
622
Angiomatoid fibrous histiocytoma in mediastinum
623
Angiomatoid Fibrous Histiocytoma, A Great Mimicker – A Short Series of 3 Cases with EWSR1 Fusion
624
Angiomyofibroblastoma mimicking an inguinal hernia: a challenging diagnosis in a male patient
625
Angiomyofibroblastoma of the Vaginal Portion
626
Angiomyofibroblastoma of the Vulva
627
Angiomyogenesis using liposome based vascular endothelial growth factor-165 transfection with skeletal myoblast for cardiac repair
628
Angiomyolipoma and Malignant PEComa: Discussion of TwoRare Adrenal Tumors
629
Angiomyolipoma of the Adrenal Gland: A Case Report
630
Angiomyoma of the Hard Palate
631
Angiomyxolipoma; Report of a new case in subcutaneous tissue and review of the literature
632
Angiomyxoma Presenting as an Unusual Vaginal Mass
633
Angioneogenesis as a possible elusive triggering factor in rheumatoid arthritis
634
Angioneogenesis in rheumatoid arthritis
635
Angioneogenesis in rheumatoid arthritis
636
ANGIOPEPTIDES: NOVEL PEPTIDES THAT INDUCE ANGIOGENESIS
637
ANGIOPLASTY AND STENTING OF BASILAR ARTERY:SHORT-TERM OUTCOMES
638
ANGIOPLASTY AND STENTING OF BASILAR ARTERY:SHORT-TERM OUTCOMES
639
Angioplasty and stenting of the distal coronary anastomosis for graft failure immediately after coronary artery bypass grafting
640
Angioplasty for acute myocardial infarction in community hospital without surgical back-up: Response to Wharton and Angelini publications “should guidelines be changed?: Not whether but when”
641
Angioplasty for coarctation in different aged patients
642
Angioplasty for intermittent claudication
643
Angioplasty for lower-limb ischaemia: time for randomised controlled trials
644
Angioplasty for the late stent thrombosis, the new technical challenge: A single centre experience
645
Angioplasty Guidewire Velocity: A New Simple Method to Calculate Absolute Coronary Blood Velocity and Flow
646
Angioplasty in the stent era: results of a consecutive series of patients undergoing coronary angioplasty without surgical backup
647
Angioplasty increases coronary sinus F2-isoprostane formation: evidence for in vivo oxidative stress during PTCA
648
Angioplasty of a left anterior descending artery originating from the right sinus of Valsalva (discussion in decision making)
649
Angioplasty of atherosclerotic and fibromuscular renal artery stenosis: time course and predicting factors of the effects on renal function
650
Angioplasty of complex lesions in ischemic rest angina: Results of the Thrombolysis and Angioplasty in Unstable Angin (TAUSA) Trial
651
Angioplasty of the internal thoracic artery bypass-graft an alternative to reoperation
652
Angioplasty or Surgery for Multivessel Coronary Artery Disease: Comparison of Eligible Registry and Randomized Patients in the EAST Trial and Influence of Treatment Selection on Outcomes
653
Angioplasty through a stent side door
654
Angioplasty versus bypass surgery
655
Angioplasty versus bypass surgery
656
Angioplasty versus bypass surgery
657
Angioplasty versus intravenous thrombolysis for acute myocardial infarction
658
Angioplasty vs medical therapy in the treatment of unilateral atherosclerotic renal artery stenosis: A prospective randomized open blinded-endpoint trial
659
Angioplasty, inflammation, and antiplatelet agents
660
Angioplasty-induced superoxide anions and neointimal hyperplasia in the rabbit carotid artery: suppression by the isoflavone trans-tetrahydrodaidzein
661
Angiopoietin 2 Level in Type 2 Diabetic Patients with Cardiovascular Complications
662
Angiopoietin like protein 3 (Angptl3), fatty acid binding protein 4 (FABP4) and homeostasis model assessment of insulin resistance (HOMA-IR) among Indonesian obese non diabetic males
663
ANGIOPOIETIN-1 AND -2 MEDIATE PROINFLAMMATORY RESPONSES IN HUMAN ENDOTHELIAL CELLS
664
Angiopoietin-1 and angiopoietin-2 in diabetes mellitus: relationship to VEGF, glycaemic control, endothelial damage/dysfunction and atherosclerosis
665
Angiopoietin-1 supports induction of hematopoietic activity in human CD34− bone marrow cells
666
Angiopoietin2 enhances doxorubin resistance in HepG2 cells by upregulating survivin and Ref-1 via MSK1 activation
667
ANGIOPOIETIN-2 IS AN AUTOCRINE REGULATOR OF ENDOTHELIAL CELL RESPONSIVENESS AND VASCULAR HOMEOSTASIS
668
Angiopoietin-like 4 Protein Elevates the Prosurvival Intracellular O2−:H2O2 Ratio and Confers Anoikis Resistance to Tumors
669
Angiopoietin-like protein 2 in psoriasis: a new linkage with metabolic syndrome
670
Angiopoietin-like protein 8 (betatrophin) may inhibit hepatocellular carcinoma through suppressing of the Wnt signaling pathway
671
Angiopoietin-like proteins: Another player in the metabolic field
672
Angiopoietin-like proteins: potential new targets for metabolic syndrome therapy
673
Angiopoietin-like-4 is a potential angiogenic mediator in arthritis
674
Angiopoietins in angiogenesis
675
Angiopoietins in malignancy
676
Angiopoietins: a link between angiogenesis and inflammation
677
Angiosarcoma after conservative treatment and radiation therapy for adenocarcinoma of the breast
678
Angiosarcoma as a sequela of breast cancer treatment with lumpectomy and radiotherapy
679
Angiosarcoma at Dialysis Fistula Site in a Patient on Continuous Ambulatory Peritoneal Dialysis
680
Angiosarcoma in the right atria demonstrated by fusion images of multislice computed tomography and positron emission tomography using F-18 Fluoro-Deoxyglucose
681
Angiosarcoma of Kidney A Case Report and Review of Literature
682
Angiosarcoma of the breast after quadrantectomy and postoperative radiotherapy for carcinoma
683
Angiosarcoma of the breast: a 30 year perspective with an optimistic outlook
684
Angiosarcoma of the chest wall
685
Angiosarcoma of the Liver Presenting with Esophageal Bleeding and Arterio-portal Shunts
686
Angiosarcoma of the liver: MR imaging pre- and post-chemotherapy
687
Angiosarcoma of the pericardium presenting as hemorrhagic pleuropericarditis, cardiac tamponade, and thromboembolic phenomena
688
Angiosarcoma of the Right Atrium with Extension to SVC and IVC Presenting with Complete Heart Block and Significant Pericardial Effusion
689
Angiosarcoma of the right atrium: A diagnostic dilemma
690
Angiosarcoma of the small intestine
691
Angiosarcoma: complication of breast conservation treatment
692
Angiosarcome mammaire primitif : à propos de deux cas
693
Angioscopic and Virtual Histology Intravascular Ultrasound Characteristics of Culprit Lesion Morphology Underlying Coronary Artery Thrombosis
694
Angioscopic Assessment of Coronary Lesions Underlying Thrombus
695
Angioscopic characteristics of coronary narrowing in patients with recurrent myocardial ischemia after myocardial infarction
696
Angioscopic Comparison of Neointimal Coverage Between Zotarolimus- and Sirolimus-Eluting Stents
697
Angioscopic Coronary Macromorphology After Thrombolysis in Acute Myocardial Infarction
698
Angioscopic detection of residual pulmonary thrombi in the differential diagnosis of pulmonary embolism
699
Angioscopic evaluation of angiographically complex coronary lesions,
700
Angioscopic evaluation of atherosclerotic plaques: Validation by histomorphologic analysis and association with stable and unstable coronary syndromes
701
Angioscopic evaluation of neointima coverage: Sirolimus drug-eluting stent versus bare metal stent
702
Angioscopic Evaluation of Rotational Atherectomy Followed by Additional Balloon Angioplasty Versus Balloon Angioplasty Alone in Coronary Artery Disease: Prospective, Randomized Study
703
Angioscopic findings during coronary angioplasty of coronary occlusions
704
Angioscopic findings of delayed healing at sites of sirolimus-eluting stent overlap after 21-month implantation
705
Angioscopic follow-up study of coronary ruptured plaques in nonculprit lesions Original Research Article
706
Angioscopic identification of coronary thrombus in patients with postinfarction angina
707
Angioscopic versus angiographic detection of thrombus during coronary interventional procedures
708
Angioscopy of Culprit Coronary Lesions in Unstable Angina Pectoris and Correlation of Clinical Presentation With Plaque Morphology
709
Angioscopy variables predictive of early angiographic outcome after excimer laser-assisted coronary angioplasty
710
Angioseal use after antegrade femoral arteriotomy in patients undergoing percutaneous revascularization for critical limb ischemia: A case series
711
Angiosome-targeted isolated tibial angioplasty for healing of ischemic foot ulcer: a retrospective study
712
Angiosperm DNA contamination by endophytic fungi: Detection and methods of avoidance
713
Angiosperms (seagrass) within the EU water framework directive: A UK perspective
714
Angiostrongylus eosinophilic meningitis in Egypt
715
Angiostrongylus vasorum from South America and Europe represent distinct lineages
716
Angiotenin II and vacular endothelial growth factor in the vitreou fluid of patient with diabetic macular edema and other retinal diorder
717
Angiotensin (1–7) and Apelin co-therapy: New strategy for heart failure treatment of rats
718
Angiotensin (1-7) Inhibits Ang II-mediated ERK1/2 Activation by Stimulating MKP-1 Activation in Vascular Smooth Muscle Cells
719
Angiotensin 1-7 Administration Increases Renal Blood Flow in the Absence of Bradykinin B2 Receptor in Ovariectomized Estradiol Treated Rats: The Role of Mas Receptor
720
Angiotensin 1-7 Receptor and Angiotensin II Receptor 2 Blockades Prevent the Increased Serum and Kidney Nitric Oxide Levels in Response to Angiotensin II Administration: Gender-Related Difference
721
Angiotensin 2 type 1 receptor blocker attenuates atrial structural remodeling in spontaneously hypertensive rats: Role of the suppression of atrial oxidative stress
722
Angiotensin and asymmetric fetal growth
723
Angiotensin and vascular fibrinolytic balance
724
Angiotensin antagonists and renal ischemia/reperfusion: Possible modulation by L-carnitine
725
Angiotensin AT2 receptor contributes to cardiovascular remodelling of aged rats during chronic AT1 receptor blockade
726
Angiotensin blockade for hypertension: a promise fulfilled
727
Angiotensin Blockade Inhibits Increased JNKs, AP-1 and NF- κ B DNA-binding Activities in Myocardial Infarcted Rats
728
Angiotensin Blockade Inhibits SIF DNA Binding Activities via STAT3 after Myocardial Infarction
729
Angiotensin converting enzyme (ACE D/I) polymorphism and its relation to liver fibrosis progression in Egyptian patients with chronic hepatitis C virus infection
730
Angiotensin Converting Enzyme (ACE) Activity Levels in Insulin-independent Diabetes Mellitus and Effect of ACE levels on Diabetic Patients with Nephropathy
731
Angiotensin converting enzyme (ACE) and non-ACE dependent angiotensin II generation in resistance arteries from patients with heart failure and coronary heart disease
732
Angiotensin converting enzyme (ACE) gene expression in experimentally induced liver cirrhosis in rats
733
Angiotensin converting enzyme (ACE) inhibitory, antihypertensive and antihyperlipidaemic activities of protein hydrolysates from Rhopilema esculentum
734
Angiotensin Converting Enzyme and Myofibroblasts during Tissue Repair in the Rat Heart
735
Angiotensin converting enzyme gene — a candidate gene for addiction to smoking?
736
Angiotensin Converting Enzyme Gene I/D Polymorphism in Pakistani Rheumatic Heart Disease Patients and Healthy Controls
737
Angiotensin converting enzyme gene insertion/deletion polymorphism, angiotensinogen gene polymorphisms, family history of hypertension, and childhood blood pressure
738
Angiotensin Converting Enzyme Gene Insertion/Deletion Variant and Familial Mediterranean Fever-related Amyloidosis
739
Angiotensin converting enzyme gene polymorphism and activity in Turkish patients with essential hypertension
740
Angiotensin converting enzyme gene polymorphism and the course of angiographically defined coronary artery disease
741
Angiotensin Converting Enzyme Gene Polymorphism in Aizheimers Disease
742
Angiotensin Converting Enzyme Gene Polymorphism in Essential Hypertension Based on Ambulatory Blood Pressure Monitoring
743
Angiotensin Converting Enzyme Gene Polymorphism in Iranian Patients with Type 2 Diabetes
744
Angiotensin Converting Enzyme Gene Polymorphism Is Not Related to Essential Hypertension in a Greek Population
745
Angiotensin Converting Enzyme I/D Polymorphism and Chronic Hepatitis C Virus Infection
746
Angiotensin Converting Enzyme I/D Polymorphism in Egyptian Patients with Type 2 Diabetes Mellitus
747
Angiotensin converting enzyme inhibition and angiotensin II AT1-receptor blockade reduce the levels of asymmetrical NG, NG-dimethylarginine in human essential hypertension
748
Angiotensin converting enzyme inhibition by captopril influences cardiac work in healthy hearts
749
Angiotensin Converting Enzyme Inhibition Corrects Na+/H+ Exchanger Overactivity in Essential Hypertension
750
Angiotensin converting enzyme inhibition, with quinapril, improves endothelial vasomotor dysfunction in patients with coronary artery disease: The TREND study (trial on reversing endothelial dysfunction)
751
Angiotensin converting enzyme inhibitor as an additive treatment after successful balloon dilation of a critical pulmonary valve stenosis
752
Angiotensin converting enzyme inhibitor captopril does not improve exercise tolerance or reduce exercise induced myocardial ischemi in patients with angin pectoris
753
Angiotensin converting enzyme inhibitor use is associated with higher bone mineral density in elderly Chinese
754
Angiotensin Converting Enzyme Inhibitor-related Angioedema: A Case of an Unexpected Death
755
ANGIOTENSIN CONVERTING ENZYME- INHIBITORS ASSOCIATED COUGH: A PROSPECTIVE EVALUATION IN HYPERTENSIVES
756
Angiotensin Converting Enzyme Inhibitors, A Risk Factor of Poor Outcome in Diabetic Patients with COVID-19 Infection
757
Angiotensin Converting Enzyme Insertion/Deletion Gene Polymorphism: An Observational Study among Diabetic Hypertensive Subjects in Malaysia
758
Angiotensin- Converting Enzyme Insertion/Deletion Polymorphism and Its Association with Coronary Artery Disease in an Iranian Population
759
Angiotensin converting enzyme insertion/deletion polymorphism in sporadic and familial Alzheimerʹs disease and longevity
760
Angiotensin I converting enzyme (ACE) gene polymorphism and essential hypertension in Japan: Ethnic difference of ACE genotype
761
Angiotensin I converting enzyme (ACE) inhibitory peptide derived from the sauce of fermented blue mussel, Mytilus edulis
762
Angiotensin I converting enzyme gene polymorphism and insulin resistance in patients with angina pectoris
763
Angiotensin I Converting Enzyme Gene Polymorphism in Chinese Patients With Hypertension
764
Angiotensin I Converting Enzyme Inhibitory Activities of Hydroalcoholic Extracts of Nardostachys jatamansi, Prangos ferulacea and Marrubium vulgare
765
Angiotensin I Modulates Ca-transport Systems in the Rat Heart Through Angiotensin II
766
Angiotensin I retention behavior on Butyl-Sepharose under linear loading chromatographic conditions
767
Angiotensin I-Converting Enzyme (ACE) Gene Polymorphism in Relation to Physical Performance, Cognition and Survival—A Follow-up Study of Elderly Danish Twins
768
Angiotensin I–converting enzyme (ACE) inhibitors and restenosis after coronary artery stenting in patients with the DD genotype of the ACE gene
769
Angiotensin I-converting enzyme (ACE) inhibitory activities of sardinelle (Sardinella aurita) by-products protein hydrolysates obtained by treatment with microbial and visceral fish serine proteases
770
Angiotensin I-converting enzyme (ACE) inhibitory peptides derived from arachin by simulated gastric digestion
771
Angiotensin I–converting enzyme and plasminogen activator inhibitor-1 gene variants: risk of mortality and fatal cardiovascular disease in an elderly population-based cohort
772
Angiotensin I–converting enzyme gene insertion/deletion polymorphism and endometrial human cancer in normotensive and hypertensive women
773
Angiotensin I-Converting Enzyme Gene Polymorphism and Acute Response to Captopril in Essential Hypertension
774
Angiotensin I-converting enzyme gene polymorphism in a low-risk European population for coronary artery disease Original Research Article
775
Angiotensin I-converting enzyme inhibitor derived from soy protein hydrolysate and produced by using membrane reactor
776
Angiotensin I-converting enzyme inhibitory compounds in white and red wines
777
Angiotensin I-converting enzyme inhibitory oligo-tyrosine peptides synthesized by α-chymotrypsin
778
Angiotensin I-converting enzyme inhibitory peptide from yellowfin sole (Limanda aspera) frame protein and its antihypertensive effect in spontaneously hypertensive rats
779
Angiotensin I-converting enzyme inhibitory peptides in douchi, a Chinese traditional fermented soybean product
780
Angiotensin I-converting enzyme inhibitory properties of lentil protein hydrolysates: Determination of the kinetics of inhibition
781
Angiotensin I–converting enzyme insertion/insertion genotype as a genetic risk factor for cardiovascular disease
782
Angiotensin I-converting enzyme-inhibitory peptide fractions from albumin 1 and globulin as obtained of amaranth grain
783
Angiotensin II (Ang II) stimulates sympathetic nerve (SNS) activity through activation of oxidative stress
784
Angiotensin II (AngII) activates nuclear factor-κB via AT1 and AT2 receptors in the kidney
785
Angiotensin II activates intermediate-conductance Ca2+-activated K+ channels in arterial smooth muscle cells
786
Angiotensin II Activates Stat5 Through Jak2 Kinase in Cardiac Myocytes
787
Angiotensin II activation of Src mediates ERK stimulation in human vascular smooth muscle cells
788
Angiotensin II and atherosclerosis
789
Angiotensin II and cardiomyocyte apoptosis in the SHR
790
Angiotensin II and Intracellular Calcium of Adult Cardiac Fibroblasts
791
Angiotensin II and the pathophysiology of cardiovascular remodeling
792
Angiotensin II and trials of cardiovascular outcomes
793
Angiotensin II antagonists block ethanol effects on the aerial righting reflex
794
Angiotensin II antagonists demonstrate greater long-term persistence versus other antihypertensive medications
795
Angiotensin II antagonists for hypertension: are there differences in efficacy?
796
Angiotensin II antagonists for hypertension: there are differences in efficacy
797
Angiotensin II antagonists for hypertension: there are differences in efficacy: The reply
798
Angiotensin II AT1 Receptor Blockade Improves Renal Perfusion in Hypercholesterolemia
799
Angiotensin II AT1 receptor blockade normalizes CD11b+ monocyte production in bone marrow of hypercholesterolemic monkeys
800
Angiotensin II AT1 receptor gene polymorphism and microalbuminuria in essential hypertension
801
Angiotensin II atherogenicity in apolipoprotein E deficient mice is associated with increased cellular cholesterol biosynthesis
802
Angiotensin II Differentially Induces Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 Production and Disturbs MMP/TIMP Balance
803
Angiotensin II directly inhibits protein synthesis in murine myotubes
804
Angiotensin II Elevates Nitric Oxide Synthase 3 Expression and Nitric Oxide Production Via a Mitogen-Activated Protein Kinase Cascade in Ovine Fetoplacental Artery Endothelial Cells
805
Angiotensin II enhances cardiac Na+/Ca2+ exchanger current via an autocrine release of endothelin
806
Angiotensin II Enhances the Expression of Giα in A10 Cells (Smooth Muscle): Relationship with Adenylyl Cyclase Activity
807
Angiotensin II increases expression and secretion of cathepsin F in cultured human monocyte-derived macrophages: An angiotensin II type 2 receptor-mediated effect
808
Angiotensin II increases phosphodiesterase 5A expression in vascular smooth muscle cells: A mechanism by which angiotensin II antagonizes cGMP signaling
809
Angiotensin II increases the expression of lectin-like oxidized low-density lipoprotein receptor-1 in human vascular smooth muscle cells via a lipoxygenase-dependent pathway
810
Angiotensin II increases the release of endothelin-I from human cultured endothelial cells but does not regulate its circulating levels
811
Angiotensin II induced hyperplasia and hypertrophy in human vascular smooth muscle cells are mediated via AT1 receptors
812
Angiotensin II Induces Apoptosis of Adult Ventricular MyocytesIn Vitro
813
Angiotensin II induces DNA injury in human umbilical artery smooth muscle cells via a mechanism which involves hydrogen peroxide
814
Angiotensin II induces IL-6 expression and the Jak-STAT3 pathway in aortic adventitia of LDL receptor-deficient mice
815
Angiotensin II induces interleukin-6 synthesis in osteoblasts through ERK1/2 pathway via AT1 receptor
816
Angiotensin II induces mitochondrial dysfunction and promotes apoptosis via JNK signalling pathway in primary mouse calvaria osteoblast
817
Angiotensin II Induces Nuclear Factor- κ B Activation in Cultured Neonatal Rat Cardiomyocytes Through Protein Kinase C Signaling Pathway
818
Angiotensin II induces phosphorylation of glucose-regulated protein-75 in WB rat liver cells
819
Angiotensin II infusion induces site-specific intra-laminar hemorrhage in macrophage colony-stimulating factor-deficient mice
820
Angiotensin II inhibition and prevention of atrial fibrillation and stroke
821
Angiotensin II inhibition during myocardial ischemia–reperfusion in dogs: effects on leukocyte infiltration, nitric oxide synthase isoenzymes activity and left ventricular ejection fraction
822
Angiotensin II inhibition of Ca2+ currents is independent of ATR1 angiotensin II receptor activation in rat adult vagal afferent neurons
823
Angiotensin II Inhibits Insulin-Induced egr-1 Expression in Mesangial Cells
824
Angiotensin II inhibits the forearm vascular response to increased arterial pressure in humans
825
Angiotensin II Mechanisms in Ischemic Heart Disease: Pathophysiology and Survival
826
Angiotensin II mechanisms in the renal responses to hypertension and diabetes mellitus.
827
Angiotensin II Modulates ANP-R2/ANP-C Receptor-mediated Inhibition of Adenylyl Cyclase in Vascular Smooth Muscle Cells: Role of Protein Kinase C
828
Angiotensin II Plays a Critical Role in Alcohol-Induced Cardiac Nitrative Damage, Cell Death, Remodeling, and Cardiomyopathy in a Protein Kinase C/Nicotinamide Adenine Dinucleotide Phosphate Oxidase–Dependent Manner
829
Angiotensin II Plays an Important Role in Maintaining Blood Pressure in Postmenopausal Women Receiving Hormone Replacement Therapy
830
Angiotensin II Potentiates DNA Synthesis in AT-1 Transformed Cardiomyocytes
831
Angiotensin II promotes ICAM-1 expression in vitro and soluble ICAM-1 secretion in vivo
832
Angiotensin II receptor antagonism does not prevent tolerance to continuous transdermal nitroglycerin
833
Angiotensin II Receptor Antagonist Blocks the Expression of Connexin43 Induced by Cyclical Mechanical Stretch in Cultured Neonatal Rat Cardiac Myocytes
834
Angiotensin II receptor antagonists Review Article
835
Angiotensin II receptor blockade and end-organ protection
836
Angiotensin II receptor blockade by losartan reduces the incidence of heart failure after an MI in rat
837
Angiotensin II receptor blockade does not improve left ventricular function andremodeling in subacute mitral regurgitation in the dog
838
Angiotensin II receptor blockade in diabetic nephropathy
839
Angiotensin II receptor blockade in diabetic nephropathy
840
Angiotensin II receptor blockade reduces expression of basic fibroblast growth factor mRNA in the balloon injured rat carotid artery. Quantification by competitive polymerase chain reaction
841
Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: The Losartan Intervention For End point reduction in hypertension (LIFE) study Original Research Article
842
ANGIOTENSIN II RECEPTOR BLOCKER VALSARTAN ENHANCES GLUCOSE-INDUCED INSULIN SECRETION
843
Angiotensin II receptor blockers and angiotensin converting enzyme inhibitors: implication of radical scavenging and transition metal chelation in inhibition of advanced glycation end product formation
844
Angiotensin II Receptor Blockers and Risk of Cancer in Patients With Systemic Hypertension
845
Angiotensin II Receptor Blockers Downsize Adipocytes in Spontaneously Type 2 Diabetic Rats With Visceral Fat Obesity
846
Angiotensin II receptor blockers: review of the binding characteristics
847
Angiotensin II Receptor Subtypes and Biological Responses in the Rat Heart
848
Angiotensin II Receptor Type 1 mRNA is Upregulated in Atria of Patients with End-stage Heart Failure
849
Angiotensin II receptors from peritransplantation through first-year post-transplantation and the risk of transplant coronary artery disease Original Research Article
850
Angiotensin II reduces alcohol intake and choice in water- or food-restricted rats
851
Angiotensin II regulates AT2 subtype receptor promoter activity and expression in rat primary endothelial cell
852
Angiotensin II regulates the cell cycle of vascular smooth muscle cells from SHR
853
Angiotensin II Release From Rabbit Intrarenal Arteries: A Critical Assessment
854
Angiotensin II signals mechanical stretch-induced cardiac matrix metalloproteinase expression via JAK-STAT pathway
855
Angiotensin II Stimulated Expression of Transforming Growth Factor-β1in Cardiac Fibroblasts and Myofibroblasts
856
Angiotensin II stimulates cardiac chloride/bicarbonate exchange activity by phosphorylation of serine 67 of AE3
857
Angiotensin II stimulates left ventricular hypertrophy in hypertensive patients independently of blood pressure
858
Angiotensin II stimulates left ventricular hypertrophy in hypertensive patients independently of blood pressure
859
Angiotensin II stimulates macrophage-mediated oxidation of low density lipoproteins Original Research Article
860
Angiotensin II stimulates phosphorylation and nuclear accumulation of R-Smad 2 in cultured cardiac fibroblasts: T-type Ca channel blockade in vascular smooth muscle cells causes G1S cell cycle arrest
861
Angiotensin II stimulates synthesis of vascular smooth muscle cell proteoglycans with enhanced low density lipoprotein binding properties
862
Angiotensin II subtype-1 receptor antagonists improve hemodynamic and renal changes without affecting glucose metabolisms in genetic rat model of non–insulin-dependent diabetes mellitus
863
Angiotensin II type 1 (AT1) receptor blockade in hypertensive women: benefits of candesartan cilexetil versus enalapril or hydrochlorothiazide
864
Angiotensin II type 1 receptor (A1166C) gene polymorphism in Egyptian adult hemodialysis patients
865
Angiotensin II type 1 receptor antagonist decreases plasma levels of tumor necrosis factor alpha, interleukin-6 and soluble adhesion molecules in patients with chronic heart failure
866
Angiotensin II type 1 receptor antagonists inhibit cell proliferation and angiogenesis in breast cancer
867
Angiotensin II Type 1 Receptor Blockade Abolishes Specific KATPChannel Gene Expression in Rats with Myocardial Ischemia
868
Angiotensin II type 1 receptor blockade improves cardiac expression of hsp72 and tolerance against ischemia/reperfusion injury in insulin resistance rat
869
Angiotensin II type 1 receptor blocker losartan attenuates locomotor, anxiety-like behavior, and passive avoidance learning deficits in a sub-chronic stress model
870
Angiotensin II type 1 receptor blocker telmisartan suppresses superoxide production and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice
871
Angiotensin II type 1 receptor blockers reduce tissue factor activity and plasminogen activator inhibitor type-1 antigen in hypertensive patients: a randomized, double-blind, placebo-controlled study
872
Angiotensin II Type 1 Receptor Gene A1166C Polymorphism Was Not Associated With Acute Coronary Syndrome in an Iranian Population
873
Angiotensin II type 1 receptor gene polymorphism and mitral valve prolapse syndrome
874
Angiotensin II Type 1 Receptor Gene Polymorphism Is Associated With Increase of Left Ventricular Mass But Not With Hypertension
875
Angiotensin II type 1 receptor polymorphisms in the cardiovascular health study: relation to blood pressure, ethnicity, and cardiovascular events
876
Angiotensin II type 1-receptor antagonism prevents type IIA secretory phospholipase A2-dependent lipid peroxidation
877
Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists
878
Angiotensin II type-I receptor antagonists in the treatment of heart failure
879
Angiotensin II upregulates transforming growth factor-β type I receptor on rat vascular smooth muscle cells
880
Angiotensin II, oxidative stress, and extracellular matrix degradation during transition to LV failure in rats with hypertension
881
Angiotensin II, Transforming Growth Factor-β1and Repair in the Infarcted Heart
882
Angiotensin II, VEGF, and diabetic retinopathy
883
Angiotensin II, VEGF, and diabetic retinopathy
884
Angiotensin II, VEGF, and diabetic retinopathy
885
Angiotensin II-dependent growth of vascular smooth muscle cells requires transactivation of the epidermal growth factor receptor via a cytosolic phospholipase A2-mediated release of arachidonic acid
886
Angiotensin II-induced C-reactive protein generation: Inflammatory role of vascular smooth muscle cells in atherosclerosis
887
Angiotensin II-induced ionic currents and signalling pathways in submandibular ganglion neurons
888
Angiotensin II-induced non-alcoholic fatty liver disease is mediated by oxidative stress in transgenic TG(mRen2)27(Ren2) rats
889
Angiotensin II-Mediated apoptosis and P53 expression in human cardiomyocytes
890
Angiotensin II-mediated Growth and Antigrowth Effects in Cultured Neonatal Rat Cardiac Myocytes and Fibroblasts
891
Angiotensin IV-evoked vasoprotection is conserved in advanced atheroma
892
Angiotensin receptor antagonists
893
Angiotensin receptor antagonists: focus on losartan
894
Angiotensin receptor blockade improves arterial distensibility and reduces exercise-induced pressor responses in obese hypertensive patients with the metabolic syndrome
895
Angiotensin receptor blockade improves myocardial beta-adrenergic receptor signaling in postinfarction left ventricular remodeling: A possible link between beta-adrenergic receptor kinase-1 and protein kinase C epsilon isoform Original Research Article
896
Angiotensin Receptor Blocker and N-Acetyl Cysteine for Reduction of Proteinuria in Patients With Type 2 Diabetes Mellitus
897
Angiotensin Receptor Blockers – finally the evidence is coming in: IDNT and RENAAL
898
Angiotensin Receptor Blockers and Cardiovascular Protection: Are We ONTARGET?
899
Angiotensin receptor blockers and diuretics as combination therapy: clinical implications
900
Angiotensin Receptor Blockers and Magnesium Status in Essential Hypertension
901
Angiotensin receptor blockers in heart failure: A work in progress
902
Angiotensin receptor blockers in heart failure: meta-analysis of randomized controlled trials
903
Angiotensin receptor blockers in the prevention of atrial fibrillation recurrence: Need for a definitive trial
904
Angiotensin receptor blockers in the prevention of atrial fibrillation recurrence: Need for a definitive trial
905
Angiotensin Receptor Blockers: Current Status and Future Prospects
906
Angiotensin receptor blockers: how important is selectivity?
907
Angiotensin receptor blockers—finally the evidence is coming in: IDNT and RENAAL
908
Angiotensin receptor neprilysin inhibitor in inotrope dependent heart failure patients: A case series
909
Angiotensin Receptor-1 Blocker Inhibits Atherosclerotic Changes and Endothelial Disruption of the Aortic Valve in Hypercholesterolemic Rabbits Original Research Article
910
Angiotensin Receptors in Cardiac and Renal Hypertrophy in Rats
911
Angiotensin receptors: history and mysteries
912
Angiotensin type 1 receptor antagonism reverses abnormal coronary vasomotion in atherosclerosis
913
Angiotensin Type 2 Receptor Gene Polymorphisms and Susceptibility to Preeclampsia
914
Angiotensin type-1-receptor antagonists reduce 6-hydroxydopamine toxicity for dopaminergic neurons
915
Angiotensin-(1–7) and vasopeptidase inhibition
916
Angiotensin-(1–7) central administration induces anxiolytic-like effects in elevated plus maze and decreased oxidative stress in the amygdala
917
ANGIOTENSIN, BRADYKININ AND CONVERTING ENZYME IN IMPOSED AND PHYSIOLOGICAL FLOW-RELATED ARTERIAL REMODELING.
918
Angiotensin, fibrinolysis, and vascular homeostasis
919
Angiotensin-Converting Enzyme (ACE) Inhibitor Angioedema: The Silent Epidemic
920
Angiotensin-converting enzyme (ACE) inhibitors revert abnormal right ventricular filling in patients with restrictive left ventricular disease
921
Angiotensin-converting enzyme (ACE), angiotensinogen (AGT), and angiotensin II type 1 receptor (AT1R) gene polymorphisms in generalized aggressive periodontitis
922
Angiotensin-converting enzyme (CD143) is abundantly expressed by dendritic cells and discriminates human monocyte-derived dendritic cells from acute myeloid leukemia-derived dendritic cells
923
angiotensin-converting enzyme 2 (ace2) gene polymorphism in patients with type 2 diabetes (t2dm) in thi-qar, iraq
924
Angiotensin-converting enzyme 2 acts as a potential molecular target for pancreatic cancer therapy
925
Angiotensin-converting enzyme activity and contractile effects of angiotensin I and II in human uteroplacental arteries
926
Angiotensin-converting enzyme and apolipoprotein B polymorphisms in coronary artery disease
927
Angiotensin-Converting Enzyme and Heart Chymase gene Polymorphisms in Hypertrophic Cardiomyopathy
928
Angiotensin-converting enzyme and p22phox polymorphisms and the risk of coronary heart disease in a low-risk Spanish population
929
Angiotensin-converting Enzyme and Renin Inhibition Activities, Antioxidant Properties, Phenolic and Flavonoid Contents of Cuphea ignea A. DC.
930
Angiotensin-Converting Enzyme Assay Optimization:Influence of Various Buffers and Their Concentrations
931
Angiotensin-converting enzyme gene deletion polymorphism modulation of onset of symptoms and survival rate of patients with heart failure
932
Angiotensin-converting enzyme gene I/D polymorphism and carotid artery disease in renovascular hypertension
933
Angiotensin-converting enzyme gene insertion/deletion polymorphism and cardiovascular disease: Identifying the guideposts for navigating the genetics landscape
934
Angiotensin-converting enzyme gene polymorphism and common carotid stiffness: The Rotterdam study
935
Angiotensin-converting enzyme gene polymorphism in a cohort of coronary angiography patients
936
Angiotensin-converting enzyme gene polymorphism in Japanese patients with hypertrophic cardiomyopathy
937
Angiotensin-converting enzyme gene polymorphism in preeclampsia and normal pregnancy
938
Angiotensin-Converting Enzyme Gene Polymorphism in Systemic Hypertension
939
Angiotensin-converting enzyme gene polymorphism influences degree of left ventricular hypertrophy and its regression in patients undergoing operation for aortic stenosis
940
Angiotensin-converting enzyme gene polymorphism interacts with left ventricular ejection fraction and brain natriuretic peptide levels to predict mortality after myocardial infarction
941
Angiotensin-converting enzyme genetic variants do not influence response to risperidone in autistic children
942
Angiotensin-converting enzyme genotype affects skeletal muscle strength in elite athletes
943
Angiotensin-Converting Enzyme Genotype Predicts Cardiac and Autonomic Responses to Prolonged Exercise Original Research Article
944
Angiotensin-Converting Enzyme Genotypes and Risk for Myocardial Infarction in Women
945
Angiotensin-Converting Enzyme I/D Polymorphism in Behçet’s Disease
946
Angiotensin-converting enzyme inhibition after myocardial infarction: the trandolapril cardiac evaluation study
947
Angiotensin-Converting enzyme inhibition and angiogenesis in myocardium of obese Zucker rats
948
Angiotensin-converting enzyme inhibition as antiatherosclerotic therapy: no answer yet
949
Angiotensin-converting enzyme inhibition but not angiotensin II type 1 receptor antagonism augments coronary release of tissue plasminogen activator in hypertensive patients
950
Angiotensin-converting enzyme inhibition enhances a subthreshold stimulus to elicit delayed preconditioning in pig myocardium
951
Angiotensin-converting enzyme inhibition in hypertensive patients is associated with a reduction in the occurrence of atrial fibrillation Original Research Article
952
Angiotensin-converting enzyme inhibition in patients with coronary artery disease and preserved left ventricular function: Ischemia Management with Accupril post–bypass graft via inhibition of angiotensin-converting enzyme (IMAGINE) compared with the othe
953
Angiotensin-converting enzyme inhibition is associated with reduced troponin release in non–ST-elevation acute coronary syndromes
954
Angiotensin-converting enzyme inhibition limits dysfunction in adjacent noninfarcted regions during left ventricular remodeling
955
Angiotensin-converting enzyme inhibition reduces monocyte chemoattractant protein-1 and tissue factor levels in patients with myocardial infarction
956
Angiotensin-converting enzyme inhibition restores the diffusing capacity for carbon monoxide in patients with chronic heart failure by improving the molecular diffusion across the alveolar capillary membrane
957
Angiotensin-converting enzyme inhibition to enhance vascular health—clinical and research models
958
Angiotensin-converting enzyme inhibition, autonomic activity, and hemodynamics in patients with heart failure who perform isometric exercise
959
Angiotensin-Converting Enzyme Inhibitor as a Marker, Not a Risk Factor, for Poor Prognosis
960
Angiotensin-converting enzyme inhibitor as a risk factor for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction Original Research Article
961
Angiotensin-converting enzyme inhibitor compliance and dosing among patients with heart failure,
962
Angiotensin-converting enzyme inhibitor dosages in elderly patients with heart failure
963
Angiotensin-converting enzyme inhibitor dosing in heart failure: What is optimal?
964
Angiotensin-converting enzyme inhibitor for epirubicin-induced dilated cardiomyopathy
965
Angiotensin-converting enzyme inhibitor meta-analysis provides misleading conclusion
966
Angiotensin-Converting Enzyme Inhibitor Prevents Plasminogen Activator Inhibitor-1 Expression in a Rat Model with Cardiovascular Remodeling Induced by Chronic Inhibition of Nitric Oxide Synthesis
967
Angiotensin-Converting Enzyme Inhibitor Therapy Affects Left Ventricular Mass in Patients With Ejection Fraction >40% After Acute Myocardial Infarction
968
Angiotensin-Converting Enzyme Inhibitor Therapy at the Time of Coronary Artery Bypass Surgery: When a Friend Turns Mean-Spirited
969
Angiotensin-converting enzyme inhibitor treatment after myocardial infarction: A selective approach for maximum benefit
970
Angiotensin-converting enzyme inhibitor use in survivors of acute myocardial infarction
971
Angiotensin-Converting Enzyme Inhibitor, Angiotensin Receptor Blocker Use, and Mortality in Patients With Chronic Kidney Disease
972
Angiotensin-converting enzyme inhibitors after myocardial infarction: Indications and timing
973
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease
974
Angiotensin-converting enzyme inhibitors and aortic rupture: a population-based case-control study
975
Angiotensin-converting enzyme inhibitors and myocardial infarction: A class effect?
976
Angiotensin-Converting Enzyme Inhibitors and Outcome Among Patients With Heart Failure and Renal Insufficiency: Need for a Prospective Study
977
Angiotensin-converting enzyme inhibitors and β-blockers in long-term treatment of dilated cardiomyopathy
978
Angiotensin-converting enzyme inhibitors as a cause of unilateral tongue angioedema in a 68-year-old woman
979
Angiotensin-converting enzyme inhibitors as a new therapy for atrial fibrillation? Controversy
980
Angiotensin-converting enzyme inhibitors as adjunctive therapy in patients with persistent atrial fibrillation
981
Angiotensin-Converting Enzyme Inhibitors Can Increase the Transvalvular Gradient Among Patients With Aortic Stenosis
982
Angiotensin-converting enzyme inhibitors in adults after the mustard procedure
983
Angiotensin-converting enzyme inhibitors in adults with cyanotic congenital heart disease
984
Angiotensin-Converting Enzyme Inhibitors in Coronary Artery Disease and Preserved Left Ventricular Systolic Function: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Original Research Article
985
Angiotensin-converting enzyme inhibitors in the management of congestive heart failure: A pharmaceutical industry perspective, ,
986
Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers for Prevention of Type 2 Diabetes: A Meta-Analysis of Randomized Clinical Trials Original Research Article
987
Angiotensin-Converting Enzyme Inhibitors Potentiate Preconditioning Through Bradykinin B2 Receptor Activation in Human Heart
988
Angiotensin-converting enzyme inhibitors prevent LDL-induced endothelial dysfunction by reduction of asymmetric dimethylarginine level
989
Angiotensin-converting enzyme inhibitors reveal non-NO-, non-prostacycline-mediated endothelium-dependent relaxation in internal thoracic artery of hypertensive patients
990
Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Antagonists and Calcium Channel Blocking Agents: Review of Potential Benefits and Possible Adverse Reactions
991
Angiotensin-converting enzyme inhibitors, beta-blockers, and mortality in systolic heart failure
992
Angiotensin-converting enzyme inhibitors: a new therapy for atrial fibrillation?
993
Angiotensin-converting enzyme inhibitors: ischemia is not the correct measure of benefit
994
Angiotensin-converting enzyme inhibitors: optimal management of cardiovascular risk
995
Angiotensin-Converting Enzyme Insertion/Deletion Gene Polymorphism in General Population of West Azarbaijan, Iran
996
Angiotensin-converting enzyme insertion/deletion polymorphism and restenosis after coronary angioplasty in unstable angina pectoris
997
Angiotensin-converting enzyme insertion/deletion polymorphism in angina pectoris with normal coronary arteriograms
998
Angiotensin-converting enzyme polymorphism (I/D) and coronary heart disease in young adults
999
Angiotensin-converting enzyme polymorphism (I/D) and coronary heart disease in young adults: Reply
1000
Angiotensin-Converting Enzyme-2 Overexpression Improves Left Ventricular Remodeling and Function in a Rat Model of Diabetic Cardiomyopathy
